Podcasts about Moderna

Dirige y presenta Juan Carlos Baruque Hernández Sumario del programa JUAN MIGUEL MARSELLA CRISÓSTOMO Sueños premonitorios. Experiencias cercanas a la muerte. Fenómenos paranormales en casas habitadas. Experiencias personales. CARLOS ALBAREDA ¿Hacia dónde nos lleva la ufología moderna? Nuestra Web: https://mundoinsolitoradio.es Contacta: +34 687 39 80 12 - Solo WhatsApp mundoinsolitoradio@hotmail.com Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

La gran pregunta del día de hoy: ¿La hipergamia es un factor CLAVE en el éxito (o fracaso) de las parejas actuales?

Neste Bitalk vamos revelar um segredo com o Ricardo Antunes... será que a frigideira vai lançar um livro?

In this video, we perform a stock analysis on the 10 Best Stocks that Barron's lists as buys in 2025. Super investors who own the stocks include Warren Buffett, Michael Burry, Chris Davis, Li Lu, and David Tepper. Their stocks? Alibaba (BABA), Alphabet (GOOGL), ASML Holdings (ASML), Berkshire Hathaway (BRKB), Citigroup (C), Everest Group (EG), Moët Hennessy Louis Vuitton (LVMH), Moderna, MRNA, Schlumberger (SLB), and Uber Technologies (UBER)Want to support Global Value? https://www.interactivebrokers.com/mkt/?src=gvp1&url=%2Fen%2Fwhyib%2Foverview.phphttps://www.patreon.com/GlobalValueAre these the best stocks to buy now? Do these "super investors" know something we don't? Find out in the video above!Thank you for watching. ❤️ Please support the channel by checking out our affiliates. All commissions are reinvested to improve the quality of videos!- TIKR is the website I use for financial data in my videos. Join me and 250,000+ investors worldwide by using TIKR in your investment analysis. Referral link - https://www.tikr.com/globalvalue- Check out Seeking Alpha Premium and score an exclusive 20% off plus a free 7 day trial! Affiliate link - https://www.sahg6dtr.com/H4BHRJ/R74QP/- Try Sharesight https://www.sharesight.com/globalvalue (remember you get 4 months free if you sign up for an annual subscription!)#superinvestors #superinvestorstocks #stockmarket2025 #stocks2025 #stockmarket #stocks #investing #valueinvesting #investor #invest #finance #valueinvestor #stockanalysis #fundamentalstockanalysis #topstocks2025 #beststocks2025 #beststockstobuynow #topstockstobuynow

This episode is sponsored by Oracle. OCI is the next-generation cloud designed for every workload – where you can run any application, including any AI projects, faster and more securely for less.  On average, OCI costs 50% less for compute, 70% less for storage, and 80% less for networking. Join Modal, Skydance Animation, and today's innovative AI tech companies who upgraded to OCI…and saved.    Offer only for new US customers with a minimum financial commitment. See if you qualify for half off at http://oracle.com/eyeonai     In this episode of Eye on AI, Craig Smith sits down with Brice Challamel, Head of AI Products and Innovation at Moderna, to explore how one of the world's leading biotech companies is embedding artificial intelligence across every layer of its business—from drug discovery to regulatory approval.   Brice breaks down how Moderna treats AI not just as a tool, but as a utility—much like electricity or the internet—designed to empower every employee and drive innovation at scale. With over 1,800 GPTs in production and thousands of AI solutions running on internal platforms like Compute and MChat, Moderna is redefining what it means to be an AI-native company.   Key topics covered in this episode: How Moderna operationalizes AI at scale GenAI as the new interface for machine learning AI's role in speeding up drug approvals and clinical trials The future of personalized cancer treatment (INT) Moderna's platform mindset: AI + mRNA = next-gen medicine Collaborating with the FDA using AI-powered systems   Don't forget to like, comment, and subscribe for more interviews at the intersection of AI and innovation.     Stay Updated: Craig Smith on X:https://x.com/craigss Eye on A.I. on X: https://x.com/EyeOn_AI     (00:00) Preview  (02:49) Brice Challamel's Background and Role at Moderna (05:51) Why AI Is Treated as a Utility at Moderna (09:01) Moderna's AI Infrastructure (11:53) GenAI vs Traditional ML (14:59) Combining mRNA and AI as Dual Platforms (18:15) AI's Impact on Regulatory & Clinical Acceleration (23:46) The Five Core Applications of AI at Moderna (26:33) How Teams Identify AI Use Cases Across the Business (29:01) Collaborating with the FDA Using AI Tools (33:55) How Moderna Is Personalizing Cancer Treatments (36:59) The Role of GenAI in Medical Care (40:10) Producing Personalized mRNA Medicines (42:33) Why Moderna Doesn't Sell AI Tools (45:30) The Future: AI and Democratized Biotech

O primeiro ciclo econômico do nosso país deu o tom para como as relações entre europeus e indígenas se dariam nos séculos seguintes. Separe trinta minutos do seu dia e aprenda com o professor Vítor Soares (@profvitorsoares) sobre o que foi o processo de exploração do Pau-Brasil.-Se você quiser ter acesso a episódios exclusivos e quiser ajudar o História em Meia Hora a continuar de pé, clique no link: www.apoia.se/historiaemmeiahoraConheça o meu canal no YouTube, e assista o História em Dez Minutos!https://www.youtube.com/@profvitorsoaresOuça "Reinaldo Jaqueline", meu podcast de humor sobre cinema e TV:https://open.spotify.com/show/2MsTGRXkgN5k0gBBRDV4okCompre o livro "História em Meia Hora - Grandes Civilizações"!https://a.co/d/47ogz6QCompre meu primeiro livro-jogo de história do Brasil "O Porão":https://amzn.to/4a4HCO8Compre nossas camisas, moletons e muito mais coisas com temática História na Lolja!www.lolja.com.br/creators/historia-em-meia-hora/PIX e contato: historiaemmeiahora@gmail.comApresentação: Prof. Vítor Soares.Roteiro: Prof. Vítor Soares e Prof. Victor Alexandre (@profvictoralexandre)REFERÊNCIAS USADAS:- MICELI, Paulo. História Moderna. São Paulo: Editora Contexto, 2023- PIGAFETTA, Antonio. A primeira viagem ao redor do mundo: o diário da expedição de Fernão de Magalhães. Porto Alegre: L&PM, 1985.- SILVA, Luiz Geraldo. A Faina, a Festa e o Rito: Uma etnografia histórica sobre as gentes do mar (séculos XVII ao XIX). Campinas: Papirus, 2001.

In der Pandemie schaffte die mRNA den Durchbruch, jetzt beginnt ein neues Kapitel für das Biomolekül. Diesmal wollen BioNTech und Moderna das Immunsystem auf Krebszellen lenken. Ihr Ziel: Eine Impfung gegen Krebs. Erste Studienergebnisse lassen hoffen. Lange, Michael; Winkelheide, Martin www.deutschlandfunk.de, Wissenschaft im Brennpunkt

In der Pandemie schaffte die mRNA den Durchbruch, jetzt beginnt ein neues Kapitel für das Biomolekül. Diesmal wollen BioNTech und Moderna das Immunsystem auf Krebszellen lenken. Ihr Ziel: Eine Impfung gegen Krebs. Erste Studienergebnisse lassen hoffen. Lange, Michael; Winkelheide, Martin www.deutschlandfunk.de, Wissenschaft im Brennpunkt

We like to think of Osmosis from Elsevier as a global community of millions of learners, connected by a desire to serve humanity and an inclination to use a diverse mix of educational resources to help them become excellent healthcare practitioners. On today's episode of Raise the Line, we're going to learn how Osmosis has created an opportunity for hundreds of those students from sixty countries to actually solidify those connections through the Osmosis Health Leadership Initiative (OHLI). Our guide to this effort is Osmosis Community Specialist Alfred Collins, who brings a keen interest in developing tech solutions to power the future of human communication to his work with OHLI.“Technology collapses barriers to communication and to understanding the nuances behind culture, behind global perspectives,” he tells host Lindsey Smith. One example he cites is how OHLI members learn about variations in the way different cultures approach collaboration, an important insight to gain as they head into team-based healthcare environments. OHLI members convene regularly over video sessions to hear from leaders in healthcare and learn about hosting successful on-campus events, among other enriching content.  They also have an opportunity to provide feedback on improving the Osmosis learning platform, and this year they're participating in a “hackathon” aimed at improving the future of healthcare. Tune in to find out more about what the OHLI program offers, how to apply, and how Alfred thinks virtual reality and AI technologies will impact the future of community building. Mentioned in this episode:Osmosis Health Leadership Initiative If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Hay un sin fin de circuitos en la Fórmula 1. Algunos han permanecido y otros han quedado en el olvido. Estos circuitos han salido de muchas mentes brillantes, pero hay una mente en particular, que particularmente ha gestado muchos de estos circuitos que hoy componen la Fórmula 1 moderna.No olvides suscribirte, dejar tu like y tus comentarios. Te leemos.

Sino e Dom tornano per un nuovo episodio tra il retrofront dei dazi, persone che creano relazioni con l'intelligenza artificiale, il cambiamento della vita tra generazioni passate e quelle future e come facilitare ed approcciare il futuro fatto di eccesso e soluzioni sintetiche.Apri il link per sottoscrivere ad un piano Zencastr usufruendo dello sconto Expatriati del 30%

Dans ce numéro du Journal des biotechs, Frédéric Gomez analyse les conséquences de la démission de Peter Marks de la FDA sur les biotechs et notamment Moderna. Il revient aussi sur la baisse du cours de Novo Nordisk et commente la récente levée de fonds de DBV Technologies.L'entretien est consacré à Hervé Affagard, directeur général de Maat Pharma. Il détaille notamment les résultats de phase III ARES pour MaaT013 dans le traitement de la maladie aiguë du greffon contre l'hôte et fait le point sur la stratégie de la biotech.Attention, investir en Bourse présente un risque de perte en capital, et le secteur des biotechs cotées amplifie ce risque. La probabilité de succès de ces sociétés est incertaine, et leur besoin de financement est régulier. En cas d'échec, la continuité de leur activité peut être menacée. Ce type d'investissement est réservé exclusivement aux particuliers avertis pleinement conscients de ces enjeux et prêts à accepter ces risques. Hébergé par Audion. Visitez https://www.audion.fm/fr/privacy-policy pour plus d'informations.

La cantante Silvina Gómez Rennella fue entrevistada en el programa “Letras y corcheas”, conducido por Mario y Hernán Dobry, el jueves 10 de abril de 2025, para conversar sobre trayectoria en el mundo de la música, sobre su álbum “El tiempo que queda” y sobre el espectáculo “Entre clásica y moderna…Lírica, jazz & blues”, que realizó en Clásica y Moderna.

Informativo de primera hora de la mañana, en el programa El Remate de La Diez Capital Radio. El Sábado nos dejó, de forma inesperada y dolorosa, José Luis Fernández, director de Radio Tiempo, emisora emblemática del municipio de Granadilla de Abona, justo en el año en que celebraba su 30º aniversario al servicio de la radio local. José Luis fue mucho más que un profesional de la comunicación: fue una voz cercana, un amigo leal y un referente indiscutible para toda la comarca. Su dedicación a la radio era total, y su compromiso con la información y con la gente de su tierra, inquebrantable. Durante tres décadas, supo construir un medio independiente, cercano y humano, siempre con una sonrisa y con la pasión que solo los verdaderos amantes de la radio saben transmitir. Desde aquí, enviamos todo nuestro cariño y fuerza a su familia, amigos y compañeros. Descansa en paz, José Luis. Muere Mario Vargas Llosa, el último gran genio de la literatura latinoamericana, a los 89 años. Hoy hace 2 años el titular era: Moderna pone fecha a su vacuna contra el cáncer. La compañía también quiere tener para 2030 sus vacunas contra enfermedades cardiovasculares. Hoy hace 2 años: Francisco García es elegido nuevo rector de la Universidad de La Laguna. Logró el 65,2% de los votos, por el 34,8% de Rosa Aguilar. Hoy se cumplen 1.143 días del cruel ataque e invasión de Rusia a Ucrania. 3 años y 48 días. Hoy es Lunes 14 de abril de 2025. Día de las Américas. El Día Mundial de la Américas, se celebra el 14 de abril y tiene como objetivo dar a conocer la soberanía, así como la unión existente entre las Repúblicas Americanas de forma voluntaria, dentro de una Comunidad Continental, para alcanzar la paz y la solidaridad de los pueblos. El verdadero propósito para la creación del Día de las Américas es buscar la vía más idónea para crear entre los países que conforman el Continente Americano, un clima de hermandad, justicia social, solidaridad y paz. Es en el año 1948, cuando en Colombia, se llevó a cabo el encuentro entre veintiún países, y donde se establecieron acuerdos dirigidos a afianzar la paz y la seguridad del Continente Americano, así como trabajar mancomunadamente para consolidad la democracia de los pueblos y la no intervención en los asuntos internos de cada nación. 1182 en España se inaugura la mezquita de Sevilla, cuyas obras se habían iniciado diez años antes. 1450 en Francia se libra la batalla de Formigný. Los franceses atacan y casi aniquilan a los ingleses, acabando así con la dominación inglesa en el norte de Francia. 1632 en la batalla de Rain, los suecos derrotaron al Sacro Imperio Romano durante la Guerra de los Treinta Años. 1865 en los Estados Unidos, John Wilkes Booth dispara al presidente Abraham Lincoln, que muere al día siguiente. 1909 en la ciudad de Adana Vilayet (Turquía) el Gobierno otomano asesina a unos 30 000 cristianos armenios (masacre de Adana). Tal día como hoy 14 de abril de 1912, El RMS Titanic chocó contra un iceberg justo antes de la medianoche del 14 de abril. El accidente del transatlántico británico se cobró la vida de miles de personas. De las 2.223 personas a bordo, solo sobrevivieron 706 personas. Del agua se recuperaron 333 cuerpos inertes. 1931 Se proclama la segunda república en España tras las elecciones generales, al conseguir las candidaturas republicanas la mayoría en 43 capitales de provincia. Ante este hecho, el rey Alfonso XIII decide abandonar el país. 1939 Roosevelt envía una carta a Hitler y Mussolini ofreciendo y pidiendo 10 años de paz en Europa y Medio Oriente. 1992 en España, se inaugura oficialmente la línea de alta velocidad Madrid-Sevilla y los servicios AVE. 2003 en los Estados Unidos se completa el mapa del genoma humano. santos Máximo, Tiburcio, Valeriano, Lamberto y Abundio. Más de 31 muertos en un ataque con misiles rusos contra la ciudad ucraniana de Sumy. Los smartphones y los ordenadores exentos de los aranceles impuestos por Trump, incluso de China. El médico de Trump afirma que está “plenamente apto” para ser presidente tras su último examen físico. España propone a la UE un nuevo instrumento para financiar de modo "más rápido" el impulso a la defensa de Europa. Belarra es reelegida líder de Podemos con un 90% de apoyos: "Es hora de volver a poner en pie una izquierda de poder" Cuerpo confía en que el PP apoye las medidas contra los aranceles: "Daría tranquilidad a empresarios y trabajadores" El IPC en Canarias se incrementa un 1,6% en marzo El dato de marzo es el más bajo registrado en Canarias desde octubre de 2024. Canarias se mantiene en marzo como la comunidad menos inflacionista en España. En el mes pasado, el Archipiélago no registra inflación, pues obtiene un IPC general del 0% respecto a febrero, lo que le permite mantener una distancia amplia respecto al promedio nacional, con el 1,6% acumulado a 12 meses isleño frente al 2,3% del país; los grupos más inflacionistas en un año son otra vez la vivienda y la hostelería, bares y restauración. Huelga de la hostelería en Canarias: se desconvoca en Las Palmas pero se mantiene en Tenerife. Manuel Fitas, portavoz de la Federación Sindical Canaria (FSC) ha dicho este sábado que el acuerdo es "absolutamente insuficiente". Un joven ingeniero canario propone un sistema para reducir los atascos en un 35%. Oliver Castilla, lagunero de 24 años, diseña un proyecto pionero con semáforos inteligentes en las autovías, ya respaldado por el Cabildo de Tenerife, que promete mejorar la movilidad sin grandes costes ni obras. Un bebé, entre las 238 personas llegadas a Canarias en cuatro embarcaciones. Otros trece menores de edad se encuentran entre los migrantes que han arribado a las Islas en las últimas horas. Y un 14 de abril de 1958: la nave espacial soviética Sputnik 2 se desintegra con el cuerpo de la perra Laika (el primer ser vivo terráqueo en el espacio) en su interior al penetrar en la atmósfera.

Bienvenidos a La Diez Capital Radio! Están a punto de comenzar un nuevo episodio de nuestro Programa de Actualidad, donde la información, la formación y el entretenimiento se encuentran para ofrecerles lo mejor de las noticias y temas relevantes. Este programa, dirigido y presentado por Miguel Ángel González Suárez, es su ventana directa a los acontecimientos más importantes, así como a las historias que capturan la esencia de nuestro tiempo. A través de un enfoque dinámico y cercano, Miguel Ángel conecta con ustedes para proporcionar una experiencia informativa y envolvente. Desde análisis profundos hasta entrevistas exclusivas, cada emisión está diseñada para mantenerles al tanto, ofrecerles nuevos conocimientos y, por supuesto, entretenerles. Para más detalles sobre el programa, visiten nuestra web en www.ladiez.es. - Informativo de primera hora de la mañana, en el programa El Remate de La Diez Capital Radio. El Sábado nos dejó, de forma inesperada y dolorosa, José Luis Fernández, director de Radio Tiempo, emisora emblemática del municipio de Granadilla de Abona, justo en el año en que celebraba su 30º aniversario al servicio de la radio local. José Luis fue mucho más que un profesional de la comunicación: fue una voz cercana, un amigo leal y un referente indiscutible para toda la comarca. Su dedicación a la radio era total, y su compromiso con la información y con la gente de su tierra, inquebrantable. Durante tres décadas, supo construir un medio independiente, cercano y humano, siempre con una sonrisa y con la pasión que solo los verdaderos amantes de la radio saben transmitir. Desde aquí, enviamos todo nuestro cariño y fuerza a su familia, amigos y compañeros. Descansa en paz, José Luis. Muere Mario Vargas Llosa, el último gran genio de la literatura latinoamericana, a los 89 años. Hoy hace 2 años el titular era: Moderna pone fecha a su vacuna contra el cáncer. La compañía también quiere tener para 2030 sus vacunas contra enfermedades cardiovasculares. Hoy hace 2 años: Francisco García es elegido nuevo rector de la Universidad de La Laguna. Logró el 65,2% de los votos, por el 34,8% de Rosa Aguilar. Hoy se cumplen 1.143 días del cruel ataque e invasión de Rusia a Ucrania. 3 años y 48 días. Hoy es Lunes 14 de abril de 2025. Día de las Américas. El Día Mundial de la Américas, se celebra el 14 de abril y tiene como objetivo dar a conocer la soberanía, así como la unión existente entre las Repúblicas Americanas de forma voluntaria, dentro de una Comunidad Continental, para alcanzar la paz y la solidaridad de los pueblos. El verdadero propósito para la creación del Día de las Américas es buscar la vía más idónea para crear entre los países que conforman el Continente Americano, un clima de hermandad, justicia social, solidaridad y paz. Es en el año 1948, cuando en Colombia, se llevó a cabo el encuentro entre veintiún países, y donde se establecieron acuerdos dirigidos a afianzar la paz y la seguridad del Continente Americano, así como trabajar mancomunadamente para consolidad la democracia de los pueblos y la no intervención en los asuntos internos de cada nación. 1182 en España se inaugura la mezquita de Sevilla, cuyas obras se habían iniciado diez años antes. 1450 en Francia se libra la batalla de Formigný. Los franceses atacan y casi aniquilan a los ingleses, acabando así con la dominación inglesa en el norte de Francia. 1632 en la batalla de Rain, los suecos derrotaron al Sacro Imperio Romano durante la Guerra de los Treinta Años. 1865 en los Estados Unidos, John Wilkes Booth dispara al presidente Abraham Lincoln, que muere al día siguiente. 1909 en la ciudad de Adana Vilayet (Turquía) el Gobierno otomano asesina a unos 30 000 cristianos armenios (masacre de Adana). Tal día como hoy 14 de abril de 1912, El RMS Titanic chocó contra un iceberg justo antes de la medianoche del 14 de abril. El accidente del transatlántico británico se cobró la vida de miles de personas. De las 2.223 personas a bordo, solo sobrevivieron 706 personas. Del agua se recuperaron 333 cuerpos inertes. 1931 Se proclama la segunda república en España tras las elecciones generales, al conseguir las candidaturas republicanas la mayoría en 43 capitales de provincia. Ante este hecho, el rey Alfonso XIII decide abandonar el país. 1939 Roosevelt envía una carta a Hitler y Mussolini ofreciendo y pidiendo 10 años de paz en Europa y Medio Oriente. 1992 en España, se inaugura oficialmente la línea de alta velocidad Madrid-Sevilla y los servicios AVE. 2003 en los Estados Unidos se completa el mapa del genoma humano. santos Máximo, Tiburcio, Valeriano, Lamberto y Abundio. Más de 31 muertos en un ataque con misiles rusos contra la ciudad ucraniana de Sumy. Los smartphones y los ordenadores exentos de los aranceles impuestos por Trump, incluso de China. El médico de Trump afirma que está “plenamente apto” para ser presidente tras su último examen físico. España propone a la UE un nuevo instrumento para financiar de modo "más rápido" el impulso a la defensa de Europa. Belarra es reelegida líder de Podemos con un 90% de apoyos: "Es hora de volver a poner en pie una izquierda de poder" Cuerpo confía en que el PP apoye las medidas contra los aranceles: "Daría tranquilidad a empresarios y trabajadores" El IPC en Canarias se incrementa un 1,6% en marzo. El dato de marzo es el más bajo registrado en Canarias desde octubre de 2024. Canarias se mantiene en marzo como la comunidad menos inflacionista en España. En el mes pasado, el Archipiélago no registra inflación, pues obtiene un IPC general del 0% respecto a febrero, lo que le permite mantener una distancia amplia respecto al promedio nacional, con el 1,6% acumulado a 12 meses isleño frente al 2,3% del país; los grupos más inflacionistas en un año son otra vez la vivienda y la hostelería, bares y restauración. Huelga de la hostelería en Canarias: se desconvoca en Las Palmas pero se mantiene en Tenerife. Manuel Fitas, portavoz de la Federación Sindical Canaria (FSC) ha dicho este sábado que el acuerdo es "absolutamente insuficiente". Un joven ingeniero canario propone un sistema para reducir los atascos en un 35%. Oliver Castilla, lagunero de 24 años, diseña un proyecto pionero con semáforos inteligentes en las autovías, ya respaldado por el Cabildo de Tenerife, que promete mejorar la movilidad sin grandes costes ni obras. Un bebé, entre las 238 personas llegadas a Canarias en cuatro embarcaciones. Otros trece menores de edad se encuentran entre los migrantes que han arribado a las Islas en las últimas horas. Y un 14 de abril de 1958: la nave espacial soviética Sputnik 2 se desintegra con el cuerpo de la perra Laika (el primer ser vivo terráqueo en el espacio) en su interior al penetrar en la atmósfera. - Sección de actualidad con mucho sentido de Humor inteligente en el programa El Remate de La Diez Capital radio con el periodista socarrón y palmero, José Juan Pérez Capote, El Nº 1. - Sección en el programa El Remate de La Diez Capital radio con nuestro abogado particular, juan Inurria. - Programa de actualidad presentado y dirigido por: Juan Antonio Inurria Rivero Colaboradores: Rita Medina-Páez. Gabriel Suárez. Patricia Fernández. Andrés Chaves - Tertulia de actualidad informativa en La Diez Capital radio de actualidad con Rosi Rivero y Matías Hernández.

Cap

Te invitamos a escucharnos todos los viernes en punto de las 18:00hrs. En compañía de Jorge Escamilla H. presentando su programa ¡La Sociedad Moderna! Hoy platicamos con sobre: -Turismo, vacaciones de semana santa. Compártenos tus comentarios y síguenos en nuestras redes sociales. Proyecto Radio MX, con Sentido Social

Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.

Tienes una oportunidad única para caer ON TRACK de la mano de Carlos Figueroa. Si estás interesado, nos gustaría saber más, toma sólo 2 minutos.https://us4.list-manage.com/survey?u=a6dbd1203de8cd57a2bcd1122&id=e406f2e034&attribution=false✨ Este episodio es auspiciado por SanoVitRevitaliza tu salud con los suplementos nutricionales de SanoVit.Experimenta una vida más saludable con productos naturales diseñados científicamente para tu bienestar integral: https://sano-vit.com/

Si liderar equipos de ventas en tecnología se ha vuelto un desafío, este episodio de "Con Licencia Para Vender" con Jorge Zamora es para ti. En una entrevista con Isaías Sharon, exploran cómo potenciar el liderazgo comercial en empresas tecnológicas y por qué tecnificarse puede marcar la diferencia tanto en producción como en ventas.

Nato a New York nel 1938, Bernie Madoff costruì un impero finanziario che lo portò ai vertici di Wall Street, guadagnandosi la fiducia di investitori e istituzioni. Per decenni fu considerato un genio della finanza, fino a quando, nel 2008, la verità emerse: il suo fondo non era altro che la più grande truffa di sempre, uno schema Ponzi da oltre 60 miliardi di dollari. La promessa di rendimenti sicuri e costanti attirò migliaia di investitori, dai piccoli risparmiatori ai grandi nomi della finanza. Ma come ha fatto Madoff a ingannare tutti per così tanto tempo? E quali sono state le conseguenze per le sue vittime e per il mondo finanziario? Proviamo a scoprirlo insieme ad Andrea Franceschi, giornalista del Sole24Ore e autore del podcast “Squali”. Iscriviti al gruppo Telegram per interagire con noi e per non perderti nessuna delle novità in anteprima e degli approfondimenti sulle puntate: https://t.me/LucePodcast Se vuoi ascoltarci senza filtri e sostenere il nostro lavoro, da oggi è possibile abbonarsi al nostro canale Patreon e accedere a contenuti bonus esclusivi tramite questo link: patreon.com/LucePodcast

Una Franja de Gaza con o sin palestinos. Es el pulso que están dando varios países. El presidente de EE. UU., Donald Trump, insiste en su idea de expulsar a los más de dos millones de habitantes del enclave para reconstruirlo y crear lo que llama una “Riviera del Medio Oriente”. Pero, muchos rechazan la idea, entre ellos los líderes de Egipto, Francia y Jordania, que se reunieron en El Cairo.  Tras su encuentro de esta semana en la Casa Blanca, el primer ministro israelí, Benjamin Netanyahu, afirma que discutió con el mandatario estadounidense, Donald Trump, lo que calificó de audaz visión: la expulsión de los palestinos de Gaza para reconstruir el devastado territorio.En una rueda de prensa en Washington junto a Benjamín Netanyahu, Trump afirmó que sería "algo bueno" que fuerzas estadounidenses asumieran el control de Gaza y volvió a abogar por el desplazamiento forzado de los gazatíes a otros países, al considerar la franja como "una oportunidad inmobiliaria".En una reunión paralela, los mandatarios de Egipto, Francia y Jordania expresaron su rechazo frontal a cualquier desplazamiento de palestinos de la Franja de Gaza y abogaron por un nuevo cese al fuego inmediato.Los tres líderes mostraron "su rechazo a cualquier desplazamiento de palestinos de sus tierras o a cualquier anexión de territorio palestino" ante la propuesta de Trump.Leer tambiénTrump asegura que dialoga directamente con Irán e insiste en que EE. UU. controle Gaza¿Qué hay detrás de este pulso por la Franja de Gaza? ¿Estados Unidos e Israel podrán sacar a los palestinos? ¿O los árabes respaldados por Francia lo evitarán?- En Buenos Aires, Martín Martinelli, historiador y doctor en Ciencias Sociales por la Universidad Nacional de Luján. Es investigador del Observatorio Geohistórico y coordinó el Grupo “Palestina y América Latina” del Consejo Latinoamericano de Ciencias Sociales CLACSO.- En Madrid, Yoel Schvartz, historiador y analista político, docente y especialista en Historia Judía Moderna.

What if the cost of writing code dropped to zero — but the cost of understanding it skyrocketed? In this episode, Hugo sits down with Joe Reis to unpack how AI tooling is reshaping the software development lifecycle — from experimentation and prototyping to deployment, maintainability, and everything in between. Joe is the co-author of Fundamentals of Data Engineering and a longtime voice on the systems side of modern software. He's also one of the sharpest critics of “vibe coding” — the emerging pattern of writing software by feel, with heavy reliance on LLMs and little regard for structure or quality. We dive into: • Why “vibe coding” is more than a meme — and what it says about how we build today • How AI tools expand the surface area of software creation — for better and worse • What happens to technical debt, testing, and security when generation outpaces understanding • The changing definition of “production” in a world of ephemeral, internal, or just-good-enough tools • How AI is flattening the learning curve — and threatening the talent pipeline • Joe's view on what real craftsmanship means in an age of disposable code This conversation isn't about doom, and it's not about hype. It's about mapping the real, messy terrain of what it means to build software today — and how to do it with care. LINKS * Joe's Practical Data Modeling Newsletter on Substack (https://practicaldatamodeling.substack.com/) * Joe's Practical Data Modeling Server on Discord (https://discord.gg/HhSZVvWDBb) * Vanishing Gradients YouTube Channel (https://www.youtube.com/channel/UC_NafIo-Ku2loOLrzm45ABA) * Upcoming Events on Luma (https://lu.ma/calendar/cal-8ImWFDQ3IEIxNWk)

Neste episódio especial falamos com Francisco Mangas, investigador do Centro de Investigação Transdisciplinar Cultura, Espaço e Memória da Universidade do Porto, sobre a história da comunidade Cigana em Portugal, no período moderno. Tentamos perceber qual a sua origem, quando chegou, porque foi discriminada e qual o seu papel na sociedade do seu tempo. Sugestões de leitura: 1. Carlos Santos Sousa - Os Maias. Retrato Sociológico de uma Família Cigana Portuguesa (1827-1957). Editora Mundos Sociais, 2013.2. Otto Rosenberg - A Lente de Aumento. Os Ciganos no Holocausto. Âncora Editora, 2001.3. Francisco Mangas - A Outra Minoria. Uma história dos Ciganos portugueses durante a Época Moderna. Tese de doutoramento apresentada à FLUP, 2024. Disponível online: https://repositorio-aberto.up.pt/handle/10216/159228-----Obrigado aos patronos do podcast:André Silva, Bruno Ricardo Neves Figueira, Cláudio Batista, Isabel Yglesias de Oliveira, Joana Figueira, NBisme, Oliver Doerfler;Alessandro Averchi, Alexandre Carvalho, Carlos Castro, Daniel Murta, David Fernandes, Domingos Ferreira, É Manel, Francisco, Hugo Picciochi, João Cancela, João Carreiro, João Pedro Tuna Moura Guedes, Jorge Filipe, Luís André Agostinho, Luisa Meireles, Patrícia Gomes, Pedro Almada, Pedro Alves, Pedro Ferreira, Rui Roque, Tiago Pereira, Vera Costa;Adriana Vazão, Alfredo Gameiro, Ana Gonçalves, Ana Sofia Agostinho, André Abrantes, André Chambel, André Silva, António Farelo, Beatriz Oliveira, Bruno Luis, Carlos Afonso, Carlos Ribeiro, Carlos Ribeiro, Catarina Ferreira, Diogo Camoes, Diogo Freitas, Fábio Videira Santos, Francisco Fernandes, Gn, Hugo Palma, Hugo Vieira, Igor Silva, João Barbosa, João Canto, João Carlos Braga Simões, João Diamantino, João Félix, João Ferreira, Joel José Ginga, José Santos, Luis Colaço, Miguel Brito, Miguel Gama, Miguel Gonçalves Tomé, Miguel Oliveira, Miguel Salgado, Nuno Carvalho, Nuno Esteves, Nuno Silva, Paulo Silva, Pedro, Pedro Cardoso, Pedro Oliveira, Pedro Simões, Peter, Ricardo Pinho, Ricardo Santos, Rúben Marques Freitas, Rui Curado Silva, Rui Rodrigues, Simão, Simão Ribeiro, Sofia Silva, Thomas Ferreira, Tiago Matias, Tiago Sequeira, Tomás Matos Pires, Vitor Couto, Zé Teixeira.-----Ouve e gosta do podcast?Se quiser apoiar o Falando de História, contribuindo para a sua manutenção, pode fazê-lo via Patreon: https://patreon.com/falandodehistoria-----Música: “Five Armies” e “Magic Escape Room” de Kevin MacLeod (incompetech.com); Licensed under Creative Commons: By Attribution 4.0 License, ⁠http://creativecommons.org/licenses/by/4.0⁠Edição de Marco António.

In his weekly clinical update, Dr. Griffin and Vincent Racaniello lament about the continuing measles outbreak, whether or not the measles outbreak was predicted, the FACTS about vaccination, high pathogenic influenza, H5N1 contaminated raw pet food, children's deaths, before Dr. Griffin reviews recent statistics on RSV, influenza and SARS-CoV-2 infections and vaccination schedules and the efficacy of Moderna's seasonal mRNA vaccine, societal burden of COVID-19 and influenza, the FDA missed deadline for approving Novovax COVID vaccine, the WasterwaterScan dashboard, where to find PEMGARDA, provides information for Columbia University Irving Medical Center's long COVID treatment center, where to go for answers to your long COVID questions, long COVID interventions, and Canada's long COVID dashboard. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode CDC buried a measles forecast that stressed the need for vaccinations….TRANSPARENCY? (Politico) Measles cases and outbreaks (CDC Rubeola) Measles 159 in Texas…. (Texas Health and Human Services) 2025 Measles outbreak guidance (New Mexico Health) Measles and rubella weekly monitoring report (Government of Canada) Enhanced epidemiological summary Measles in Ontario (Public Health Ontario) Measles and rubella weekly monitoring report (Government of Canada) Enhanced epidemiological summary Measles in Ontario (Public Health Ontario) Measles exposures in Ontario (Public Health Ontario) Measles vaccine recommendations from NYP (jpg) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Raw cat food tests positive for H5N1 (CIDRAP) Influenza: Waste water scan for 11 pathogens WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Respiratory virus activity levels (CDC Respiratory Illnesses) FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Early impact of RSV vaccination in older adults in England (Lancet) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Evaluating the effectiveness of 2024-2025 seasonal mRNA-1273 vaccination against covid-19-associated hospitalizations and medically attended covid-19 among adults aged ≥ 18 years in the united states(medRxiv) Current Moderna vaccine 53% effective against COVID hospitalization?(CIDRAP) Preliminary estimates of COVID-19 burden for 2024-2025 (CDC COVID-19) Estimated range of annual burden of flu in the US from 2010 – 2024 (CDC-flu burden) US FDA missed the deadline for decision on Novavax's COVID-19 vaccine (Reuters) Interim clinical considerations for use of COVID-19 vaccines in the United States (CDC Vaccines & Immunizations) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Fusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Metformin alleviates inflammatory response and severity rate of COVID-19 infection in elderly individuals(Scientific Reports) Drug interaction checker (University of Liverpool) Infectious Disease Society guidelines for treatment and management (ID Society) Cost-effectiveness analysis of nirmatrelvir/ritonavir for high-risk individuals with COVID-19….does this mean use the big button calculator? (OFID) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reinfection with SARS-CoV-2 in the omicron era is associated with increased risk of post-acute sequelae of SARS-CoV-2  infection: a recover-EHR cohort study(medRxiv) CAN-PCC RecMap, your one-stop shop for recommendations about Post COVID-19 Condition (Long COVID) (Canadian Guidelines for post COVID-19 condition) Letters read on TWiV 1206 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

David Game remembers the days when the use of digital technology in education publishing amounted to putting a dictionary on a compact disc. Now, as the senior vice president of Product Management, Global Medical Education at Elsevier, he oversees a suite of learning materials that use artificial intelligence, virtual reality and 3-D modeling. “We've expanded into immersive technology with Apple Vision Pro that enables you to be inside the human body, to see and explore the human heart from the inside out and it is absolutely stunning,” says Game, whose long career in publishing includes experience in North America, the United Kingdom, Europe, China and India. As Game has witnessed first-hand, advancements in ed tech, including distance learning, have provided students with an array of options and modalities to choose from that accommodate different learning styles and life circumstances, and that puts a premium on being able to meet students where they are. “We want to make sure that students find learning from our materials engaging, efficient, and aligned with how they live their lives and do their work.” Join host Lindsey Smith for this fascinating episode of Raise the Line to learn how Elsevier is leveraging the innovations offered by Osmosis, Complete Anatomy and ClinicalKey Student to enrich the learning of medical students on their journey to becoming excellent clinicians.Mentioned in this Episode:Complete AnatomyClinicalKey StudentOsmosis If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

What if building software felt more like composing than coding? In this episode, Hugo and Greg explore how LLMs are reshaping the way we think about software development—from deterministic programming to a more flexible, prompt-driven, and collaborative style of building. It's not just hype or grift—it's a real shift in how we express intent, reason about systems, and collaborate across roles. Hugo speaks with Greg Ceccarelli—co-founder of SpecStory, former CPO at Pluralsight, and Director of Data Science at GitHub—about the rise of software composition and how it changes the way individuals and teams create with LLMs. We dive into: - Why software composition is emerging as a serious alternative to traditional coding - The real difference between vibe coding and production-minded prototyping - How LLMs are expanding who gets to build software—and how - What changes when you focus on intent, not just code - What Greg is building with SpecStory to support collaborative, traceable AI-native workflows - The challenges (and joys) of debugging and exploring with agentic tools like Cursor and Claude We've removed the visual demos from the audio—but you can catch our live-coded Chrome extension and JFK document explorer on YouTube. Links below. JFK Docs Vibe Coding Demo (YouTube) (https://youtu.be/JpXCkuV58QE) Chrome Extension Vibe Coding Demo (YouTube) (https://youtu.be/ESVKp37jDwc) Meditations on Tech (Greg's Substack) (https://www.meditationsontech.com/) Simon Willison on Vibe Coding (https://simonwillison.net/2025/Mar/19/vibe-coding/) Johnno Whitaker: On Vibe Coding (https://johnowhitaker.dev/essays/vibe_coding.html) Tim O'Reilly – The End of Programming (https://www.oreilly.com/radar/the-end-of-programming-as-we-know-it/) Vanishing Gradients YouTube Channel (https://www.youtube.com/channel/UC_NafIo-Ku2loOLrzm45ABA) Upcoming Events on Luma (https://lu.ma/calendar/cal-8ImWFDQ3IEIxNWk) Greg Ceccarelli on LinkedIn (https://www.linkedin.com/in/gregceccarelli/) Greg's Hacker News Post on GOOD (https://news.ycombinator.com/item?id=43557698) SpecStory: GOOD – Git Companion for AI Workflows (https://github.com/specstoryai/getspecstory/blob/main/GOOD.md)

This is Jen's first podcast. Hear her transformative story from being in lock-down fear in the UK, wearing masks indoors to her diagnosis with a rare, aggressive childhood cancer. She talks about her 3 boys, chemo experience, hospital hardships and then becoming awake and using her voice despite others, radically changing her diet, losing her leg, finding her soul and within that... the journey continues. For the "Just Be Practice" she asked me to showcase Alexia Chellum's song "The Power is Here Now." I invite you to help Jen financially on her journey. See the links below.Be there for Jen:Search "Help Jen Thrive"Go Fund Me: https://www.gofundme.com/f/help-jen-thrive-healing-from-rare-cancer-plus-amputationFB: https://www.facebook.com/profile.php/?id=61573109420690*Host Eden Koz is a soul realignment specialist utilizing such gifts as psychological empathy, intuition, psychic ability, mediumship, meditation, mindset shift, Reiki, dimensional and galactic healing, to name a few. She can also perform a spiritual Co#id Vac+ Healing as well as remote & face-to-face sessions with individuals and groups. Contact info for Eden Koz / Just Be®, LLC:Website: EdenJustBe.com Socials: Insta, FB, FB (Just Be), LinkedIn Just Be~Spiritual BOOM Podcast can be found on the audio directories: Apple Podcasts, Spotify, Amazon Music, Stitcher, iHeart Radio, TuneIn+Alexa, ...

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Daniel Eckert über Börsen zwischen Hoffen und Bangen, die Verkaufs-Flaute bei Tesla und hochtrabende Pläne für Hut 8. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate oder regelmäßig per Sparplan. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch. Das Buch zum Podcast? Jetzt lesen. Zoll-Angst bei Pharma & Autos. Behörden-Angst bei Moderna, BioNTech, Sarepta & Sartorius. Giga-IPO bei Newsmax. Deals bei: Aston Martin, AMD, Globalfoundries, United Microelectronics, Rocket Companies, Mr. Cooper & Fortnox. Die Lieblingsaktie von Bill Gates. Eine Automatisierungswette. Halb so viel Volatilität wie die Börse. Das ist Waste Management (WKN: 893579). Tom Tailor, die Wolverhampton Wanderers und der Erfinder des Kinderwagens haben eins gemeinsam: Sie gehören Fosun (WKN: A0MVLL). Diesen Podcast vom 01.04.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

Hoy nos quitamos el filtro y hablaremos de esas "ideas modernas" que nos dejan mucho que pensar. Desde el sexo casual como empoderamiento femenino, hasta el significado de ser una super mamá en la actualidad. ¡No nos guardaremos nada! Prepárense para risas, reflexion y opiniones controversiales y tal vez, solo tal vez, un poco de sabiduría millennial.¡Únete a esta conversación! Cuéntennos en los comentarios que cosas modernas las tienen igual de confundidas. ¡Queremos saber qué no estamos solas en esto!Compra nuestro merch: doscabraslocas.comNo olvides:- Suscribirte a nuestro canal para más contenido de entretenimiento, bienestar emocional y amor propio- Activar la campanita para no perderte ningún episodio- Compartir este video con alguien que necesite escucharloHoy nos quitamos el filtro y hablaremos de esas "ideas modernas" que nos dejan mucho que pensar. Desde el sexo casual como empoderamiento femenino, hasta el significado de ser una super mamá en la actualidad. ¡No nos guardaremos nada! Prepárense para risas, reflexion y opiniones controversiales y tal vez, solo tal vez, un poco de sabiduría millennial.¡Únete a esta conversación! Cuéntennos en los comentarios que cosas modernas las tienen igual de confundidas. ¡Queremos saber qué no estamos solas en esto!Compra nuestro merch: doscabraslocas.comNo olvides:- Suscribirte a nuestro canal para más contenido de entretenimiento, bienestar emocional y amor propio- Activar la campanita para no perderte ningún episodio- Compartir este video con alguien que necesite escucharlo00:00 Intro04:20 Cosas modernas con las que no estamos de acuerdo05:30 Sexo casual como empoderamiento femenino16:30 El ideal de "La super mamá"29:05 La cultura de la cancelación, el exceso de la sensibilidad y la híper ofensa

Wall Street moderated as investors remained cautious ahead of upcoming tariffs set to take effect on Liberation Day. Concerns over slowing manufacturing activity added to broader growth fears, while falling interest rates signaled expectations of three rate cuts in the US this year. In corporate news, Tesla shares rebounded ahead of its quarterly sales report, while Johnson & Johnson declined after a judge's ruling. Moderna continued its slump, weighed down by FDA-related developments. Meanwhile, commodities softened, pressured by growth concerns and Aussie shares are expected to consolidate on Wednesday following yesterday’s strong gains. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Featuring the latest news on continuing mitigation efforts, global updates and adverse effects reports. Top News, WHO launhes pandemic probe into causes, a new published Lancet article highlights good news about natural immunity, and Pfizer and Moderna expect revies to continue to fall due to lower vaccine demands.

P1:s veckomagasin om Sverige och världen politik, trender och analyser. Lyssna på alla avsnitt i Sveriges Radio Play. I första timmen:Demokratin står på spel i Recep Tayyip Erdogans Turkiet efter gripandet av oppositionsledaren Ekrem Imamoglu – och en svensk journalist sitter fängslad i Istanbul. Hör den turkiska exiljournalisten Bülent Kenes och SVT:s Turkietkorrespondent Tomas Thorén.Under veckan har protester skakat både Israel – mot det som kallas Netanyahus försök att underminera demokratin – och Gaza, ovanligt nog mot Hamas. Reportage av Cecilia Uddén.Prinsessan Madeleine har börjat sälja hudvårdsprodukter, brittiska Prins Harrys Megan Markles gör mat- och livsstilsprogram och norska prinsessan Märtha Louise lanserar en ginprodukt inför sitt bröllop. Historikern Dick Harrisson resonerar om varför monarker har börjat ägna sig åt varumärkesbyggande och försäljning.Den så kallade regelbaserade världsordningen är i gungning. Vad går den egentligen ut på, vilka andra världsordningar har funnits – och vad kan vi vara på väg mot? Reportage av Klara von Gegerfelt.Krönika av Amat Levin.Panelen med Kajsa Kettil, Borås Tidning, Göran Greider, Dalademokraten och Tobias Wikström, Dagens Industri.I andra timmen:Tusentals personer befaras ha omkommit i Sydostasien efter den kraftfulla jordbävningen i Myanmar på fredagsmorgonen. Sveriges Radios Axel Kronholm är på plats i Bangkok, en av de städer som drabbats.Intervju med författaren och nobelpristagaren Svetlana Aleksijevitj i samband med hennes Sverigebesök i veckan, av Fredrik Wadström.Den globala uppvärmningen slår hårdast mot nordligaste Sverige och i vinter har länsstyrelserna i norr varnat för vinterturare för snöbrist, blanka isar som är svåra att ta sig över och vattendrag som inte håller för skoteröverfart. Magdalena Martinsson följer med en hundspannsförare som kämpar mot regn och snöbrist.USA:s president Donald Trump har tagit över som ordförande på kulturhuset Kennedy center – som är något av en nationalscen för kulturen i USA – och det ska enligt honom bli mindre "Woke”. Och i torsdags skrev han under ett presidentdekret i Vita huset som ska förändra en hel del kultur, bland annat på Smithsonian – världens största museum. Hör journalisten Karin Henreksson.Tre månader efter bränderna i Los Angeles står många husägare inför beslutet om det är värt att bygga upp det förstörda huset på nytt eller inte. Roger Wilson har träffat husbyggare och husägare i det drabbade området. Drygt 25 år sedan fredsuppgörelsen på Nordirland är delar av Belfast fortfarande delat. Följ Pontus Mattsson i en taxifärd genom staden.Kåseri av Emil Jensen.Programledare: Jesper LindauProducent: Mårten FärlinTekniker: Ludvig Matz

DITCH YOUR DOCTOR! https://www.livelongerformula.com/wam Get a natural health practitioner and work with Christian Yordanov! Mention WAM and get a FREE masterclass! HELP SUPPORT US AS WE DOCUMENT HISTORY HERE: https://gogetfunding.com/help-wam-cover-history/ GET NON-MRNA FREEZE DRIED MEAT HERE: https://wambeef.com/ Use code WAMBEEF to save 20%! GET HEIRLOOM SEEDS & NON GMO SURVIVAL FOOD HERE: https://heavensharvest.com/ USE Code WAM to save 5% plus free shipping! GET YOUR APRICOT SEEDS at the life-saving Richardson Nutritional Center HERE: https://rncstore.com/r?id=bg8qc1 Josh Sigurdson reports on the news of Big Pharma biotech billionaire and inventor of cancer drug Abraxane, Dr. Patrick Soon-Shiong declaring that the Covid "vaccine" has caused a massive uptick in cancer. Dr. Soon-Shiong is also the owner of the LA Times which has pushed pro covid vaccine propaganda on the masses for years including just recently. This is a big admission but obviously years late. The doctor pointed out that he's seeing metastatic pancreatic cancer in children as young as 13 which is extremely unusual. Pancreatic cancer usually only affects people 70 and older. It was a shock in 1991 when Michael Landon, actor and legendary TV producer was diagnosed with pancreatic cancer at 54 years old and died within 12 weeks. That was considered young. Now, here we are 3 decades later and it's being normalized to see young teens die from the horrible ailment. Moderna had previously confirmed last year that their mRNA "vaccines" cause cancer and in an exposed coverup, Pfizer had acknowledged behind closed doors that their injections did the same. Meanwhile, the latest normalization of disease related fear continues as Bird Flu propaganda is painted all over the media with claims that bobcats are spreading it as well as cat food. This is clearly an intro to the agenda to target the food supply and inject store bought meats with modRNA while simultaneously restricting food to rations. This is something the WEF has proclaimed they want to do so don't be surprised if we shift in that direction fast. In this video, we break down the latest propagandist claims and the real solutions before our eyes. Stay tuned for more from WAM! Get local, healthy, pasture raised meat delivered to your door here: https://wildpastures.com/promos/save-20-for-life/bonus15?oid=6&affid=321 USE THE LINK & get 20% off for life and $15 off your first box! SIGN UP FOR HOMESTEADING COURSES NOW: https://freedomfarmers.com/link/17150/ Get Prepared & Start The Move Towards Real Independence With Curtis Stone's Courses! GET YOUR WAV WATCH HERE: https://buy.wavwatch.com/WAM Use Code WAM to save $100 and purchase amazing healing frequency technology! GET ORGANIC CHAGA MUSHROOMS HERE: https://alaskachaga.com/wam Use code WAM to save money! See shop for a wide range of products! GET AMAZING MEAT STICKS HERE: https://4db671-1e.myshopify.com/discount/WAM?rfsn=8425577.918561&utm_source=refersion&utm_medium=affiliate&utm_campaign=8425577.918561 USE CODE WAM TO SAVE MONEY! GET YOUR FREEDOM KELLY KETTLE KIT HERE: https://patriotprepared.com/shop/freedom-kettle/ Use Code WAM and enjoy many solutions for the outdoors in the face of the impending reset! BUY GOLD HERE: https://firstnationalbullion.com/schedule-consult/ PayPal: ancientwonderstelevision@gmail.com FIND OUR CoinTree page here: https://cointr.ee/joshsigurdson JOIN US on SubscribeStar here: https://www.subscribestar.com/world-alternative-media For subscriber only content! Pledge here! Just a dollar a month can help us alive! https://www.patreon.com/user?u=2652072&ty=h&u=2652072 BITCOIN ADDRESS: 18d1WEnYYhBRgZVbeyLr6UfiJhrQygcgNU World Alternative Media 2025

Finalizaban los años 80 y, sumado al naufragio sistémico, los nuevos aires latentes en una generación ansiosa de cambios estremecieron los cimientos de la llamada "nueva trova". Víctima del desgaste propio de las etiquetas ya no parecía tan nueva. En vano intento de prolongar el efecto molde la oficialidad intentó encapsular el importante cambio generacional en otra etiqueta: la "novisima trova". En las canciones de Santiago Feliú resonaba, inequívocamente, aquel espíritu incisivo y renovador que incidió en las artes en el mismo centro de lo que fue punzante antesala de los durísimos y definitorios años 90. Definieron esa franja en transición en la obra del Santi los álbumes "Para mañana" (1988); "Náuseas de fin de siglo" (1991) y "Futuro inmediato" (1999). Con un histórico concierto en las tablas del teatro Amadeo Roldán (antigüo "Auditorium") la Orquesta de Música Moderna salió a la palestra musical el 12 de mayo de 1967. En su formación algunos músicos que, en paralelo, desarrollaban el embrión de lo que en 1973 pasó a ser "Irakere" una de las bandas más progresivas del jazz y la música popular bailable de su tiempo. En La Habana del año 1944 el ingeniero de sonido Ramón Sabat sentaba con sus producciones el primer esfuerzo de discografia independiente en la isla. Su etiqueta Panart con una producción sostenida de discos de 78 revoluciones x minuto, muy pronto de convirtió en referente dentro y fuera de Cuba. Orlando Guerra, "Cascarita", descollaba en su catálogo inicial con la orquesta del trompetista Julio Cueva. La rapidez con que prensaba sus discos le permitió a Sabat desbancar a competidores extranjeros de importancia. Entre ellos el poderoso emporio RCA Víctor. El trío La Rosa, la "Sonora Matancera" y el Conjunto Casino nos recuerdan aquellas veteranas ediciones Panart de la segunda mitad de los años 40. Algunos de los tesoros de la música popular cubana, todas las semanas, los compartimos contigo. A los minutos finales le pone arte, sabor y sentimiento soneros el gran Carlos Embale. En tres tiempos le acompañan el conjunto del guitarrista y compositor santiaguero Ñico Saquito, el Conjunto CubaSon y el Septeto "Nacional" del eterno poeta del son: Ignacio Piñeiro.

DITCH YOUR DOCTOR! https://www.livelongerformula.com/wam Get a natural health practitioner and work with Christian Yordanov! Mention WAM and get a FREE masterclass! HELP SUPPORT US AS WE DOCUMENT HISTORY HERE: https://gogetfunding.com/help-wam-cover-history/ GET NON-MRNA FREEZE DRIED MEAT HERE: https://wambeef.com/ Use code WAMBEEF to save 20%! GET HEIRLOOM SEEDS & NON GMO SURVIVAL FOOD HERE: https://heavensharvest.com/ USE Code WAM to save 5% plus free shipping! GET YOUR APRICOT SEEDS at the life-saving Richardson Nutritional Center HERE: https://rncstore.com/r?id=bg8qc1 Josh Sigurdson reports on the news of President Donald Trump nominating Biden appointee and vaccine zealot Dr. Susan Monarez as CDC Director, a woman opposed to RFK Jr.'s views and someone who just recently called on children as young as 6 months to be injected with the deadly covid "vaccine." As we warned, RFK Jr. got confirmed by an Israel First pharma funded congress and senate. There's a reason for that. He has met recently with the CEOs of Pfizer and Moderna as well as with Bill Gates who don't seem to be worried. In fact, he's recently stated he will not touch the vaccine schedule nor get rid of the Covid vaccines. Dr. Susan Monarez who is a longtime federal "health" bureaucrat is replacing the initial nominee David Weldon who was more in line with RFK Jr.'s views. This is just the latest evidence that the state will not save you from the state or shadow government which is of course eugenicist at its core. Not to mention the mRNA cancer vaccines being put forward by Trump with 500 billion dollars or the shift into total global technocracy while the food supply is destroyed under the guise of "Bird Flu." The same conspiracy carries on while most sit on their hands. Stop sitting on your hands. Stay tuned for more from WAM! Get local, healthy, pasture raised meat delivered to your door here: https://wildpastures.com/promos/save-20-for-life/bonus15?oid=6&affid=321 USE THE LINK & get 20% off for life and $15 off your first box! SIGN UP FOR HOMESTEADING COURSES NOW: https://freedomfarmers.com/link/17150/ Get Prepared & Start The Move Towards Real Independence With Curtis Stone's Courses! GET YOUR WAV WATCH HERE: https://buy.wavwatch.com/WAM Use Code WAM to save $100 and purchase amazing healing frequency technology! GET ORGANIC CHAGA MUSHROOMS HERE: https://alaskachaga.com/wam Use code WAM to save money! See shop for a wide range of products! GET AMAZING MEAT STICKS HERE: https://4db671-1e.myshopify.com/discount/WAM?rfsn=8425577.918561&utm_source=refersion&utm_medium=affiliate&utm_campaign=8425577.918561 USE CODE WAM TO SAVE MONEY! GET YOUR FREEDOM KELLY KETTLE KIT HERE: https://patriotprepared.com/shop/freedom-kettle/ Use Code WAM and enjoy many solutions for the outdoors in the face of the impending reset! BUY GOLD HERE: https://firstnationalbullion.com/schedule-consult/ PayPal: ancientwonderstelevision@gmail.com FIND OUR CoinTree page here: https://cointr.ee/joshsigurdson JOIN US on SubscribeStar here: https://www.subscribestar.com/world-alternative-media For subscriber only content! Pledge here! Just a dollar a month can help us alive! https://www.patreon.com/user?u=2652072&ty=h&u=2652072 BITCOIN ADDRESS: 18d1WEnYYhBRgZVbeyLr6UfiJhrQygcgNU World Alternative Media 2025

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com Innovative mRNA technology, equitable vaccine distribution, and collaborations are transforming the vaccine landscape and addressing global health challenges. In this episode, Hamilton Bennett, senior director of vaccine access and partnerships at Moderna, shares her excitement about Moderna's innovative mRNA technology and its potential to transform the vaccine landscape, emphasizing equitable vaccine development and distribution. She discusses Moderna's collaboration with governments and stakeholders to build resilient health systems, the importance of understanding community needs, and the "mRNA Access Program" for academic researchers. She also highlights the need for collaboration, cutting-edge research, and global health equity, encouraging listeners to stay informed through Moderna's LinkedIn and website. Tune in and discover the transformative potential of Moderna's mRNA technology in the vaccine field. Resources: Connect with and follow Hamilton Bennett on LinkedIn. Follow Moderna on LinkedIn and visit their website.  Fast Track Your Business Growth: Outcomes Rocket is a full service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com

*The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.A recent journal entry titled “Need for Validation of Vaccination Programs,” by Okamura Memorial Hospital Cardiovascular surgeon Dr. Kenji Yamamoto of Japan, is calling for an assessment of CoV-shot damage by halting their use temporarily, getting rid of evaluation/approval officials who have conflicts of interest, and figuring out what caused 600,000 excessive deaths in the country (with an elderly population factored in). Dr. Yamamoto writes: “Recent vaccines, including those for Japanese encephalitis, cervical cancer, and coronavirus, have shown a low but significant risk of serious autoimmune conditions, such as acute disseminated encephalomyelitis and Guillain–Barré syndrome, as potential adverse events.” He adds: “Moreover, there has been a rise in cases of shingles, monkeypox, syphilis, severe streptococcal infections, measles, sepsis, and post-operative infections in countries administering multiple vaccine doses… Ironically, mRNA vaccines, initially introduced as a solution for infection control, have instead triggered an increase in infections.”In simple terms, these shots were causing “infections” and triggering “autoimmune conditions.”  The definition of an “infection” is “contamination,” to put something foreign into a local body. The definition of a “virus” is “slimy liquid, poison,” which means any substance of the like that can cause harm. Therefore, these shots inject a virus-liquid into a body that then becomes infected.  A recent phase one trial of personalized cancer shots at Icahn School of Medicine at Mount Sinai, is based on “training the immune system to recognize unique cancer mutations, called neoantigens, and mount a stronger, targeted response.” But if the body is already reacting as it should to disease and one trains it to attack that process, it will certainly cause the body to attack itself, i.e., autoimmune disease. And if mRNA guides DNA, then gene therapy product might very well cause cancer by altering the body's regulation of gene activation and cellular reproduction. Dr. Yamamoto is right and his call for concern is simply logical and concerning. Japan also has one of the lowest vaccine trust indexes in the world when factoring in accessibility, and although most of the population reportedly took CoV-shots in particular, there is a high possibility that people just as easily reported to have taken them in order to maintain peace just as it is probably they actually took them for the same reasons, especially considering the overall hesitancy of the country. However, Japan has very low rates, or no increase, in blood clots.After all Japan banned MMR in the 1990s, pulled Moderna vaccines due to contamination, and revised their vaccine laws in the same decade to make vaccination a civic duty rather than a legal obligation. Perhaps this is why Japan got a special Japanese shot in 2024 called replicon, the first self-replicating CoV-shot. Don't trust those other ones, try the Japanese one they were told.-FREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVEX / TWITTER FACEBOOKMAIN WEBSITECashApp: $rdgable EMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/tst-radio--5328407/support.

An interesting new study from the Geisinger health system in Pennsylvania examining if genomic screening in a large population increases the identification of disease risk prompted Raise the Line to re-release a previous episode about a textbook designed to help all medical providers understand the clinical applications of genomic testing. Genomics in the Clinic: A Practical Guide to Genetic Testing, Evaluation, and Counseling from Elsevier Science Direct dives into the use of this important tool in diagnosis and screening, indicating how individuals may respond to drug therapies, and more. “We really need to educate all healthcare providers about the practice of genetics because they're going to be involved directly or indirectly in genetic testing and conveying information about what the results mean to patients and their families,” explains co-author Dr. Ethylin Wang Jabs, enterprise chair of the Department of Clinical Genomics for Mayo Clinic. Jabs and her co-author, Dr. Antonie Kline, director of Clinical Genetics at the Harvey Institute for Human Genetics at Greater Baltimore Medical Center, chose a format that makes heavy use of case studies to help readers get a better grasp on this complicated field and they also include chapters on direct-to-consumer testing and the ethical and social implications in genomic medicine. “Any kind of potentially predictive testing can have ethical issues related to it, including insurance coverage, testing for family members, protections for minors, and more,” says Dr. Kline. Join host Caleb Furnas for an illuminating episode on an area of discussion in medicine that's growing in importance as the use of genetic testing rapidly increases. Mentioned in this episode: Genomics in the Clinic: A Practical Guide If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Genentech VP, CMO Erica Taylor joins The Current Podcast to share her unique journey from immunology to biotech marketing, and the evolving role of biotech brands in mainstream media.  Episode TranscriptPlease note, this transcript  may contain minor inconsistencies compared to the episode audio.Kat Vesce (00:00):I'm Kat Vesce. And I'm Ilyse Liffreing and welcome to this edition of The Current Podcast. In honor of International Women's Day and Women's Month, we're spotlighting trailblazing women in marketing at this year's South by Southwest.Ilyse Liffreing (00:16):For this episode, we're excited to be joined by Erica Taylor, vice president and chief marketing Officer at Genentech, a company at the forefront of biotech innovation for over 40 years.Kat Vesce (00:28):Erica has a unique background transitioning from a PhD in immunology and a product development into the world of marketing, bringing a scientific perspective to how Genentech connects with global healthcare providers and patients.Ilyse Liffreing (00:41):We'll dive into how that background informs her approach to marketing, the game changing campaign she's led, and how the biotech industry is evolving to embrace more creative, emotionally driven storytelling.Kat Vesce (00:54):Plus Erica will share her perspective on how women in STEM can break barriers and what the future of healthcare marketing holds. Let's get started.Ilyse Liffreing (01:01):So Erica, thanks for being here at South by Southwest. Thanks for having me. Of course. So you have a unique background for a CMO growing part of your career on the product development side of biotech. After earning your PhD from Stanford Medical School, what drew you to the marketing side of biotech and why don't we see more medical students transition into heading up marketing departments?Erica Taylor (01:25):Yeah, I sometimes think that I have the habit of just showing up in places I'm not supposed to be, and so I certainly didn't go into my studies in immunology with the idea that I was going to end up in marketing. I would've never have thought that that would be the case. It really sort of became apparent to me that I was very much interested in the intersection of business and science when I was nearing the end of my graduate program, but I wasn't really sure how to do that or how to get there. So I explored a lot and I often share when I do development conversations with folks in the industry that I've probably not gotten more jobs than I've gotten in my life trying to figure out how to be in these other spaces. But for me, the journey really started in consulting.(02:07):I was in management consulting for biotech and pharma industry, and that is what led me to Genentech. And at my career there I have had roles in analytics and in sales, and it was probably my time in sales that really got me interested in marketing. And so I was able to sort of land a role in marketing and to do so at a company that innovates on science. I think they were able to sort of see, okay, she maybe doesn't have a background in marketing, but she understands the science, she understands how to communicate it and what actually moves markets when you're in the sales field.Ilyse Liffreing (02:38):How has that background informed your approach as a CMO? Why is that scientific medical knowledge and maybe even sales knowledge so valuable?Erica Taylor (02:48):Yeah, I think one of the things that was a bit of an aha for me in my sales role was I'll say one of the most professionally transformative experiences I had, which is code for saying it was the hardest thing I've ever done. And you learn a lot about what actually motivates people in the decisions that they make. And marketing is really focused on influencing a decision that people make and you realize even though I have a background in science and people very much need to understand why they're making the decision they're making. If you're a provider making a prescribing decision or a patient choosing between options for medicines available to you, you need to understand the why of that. But really there has to be some kind of emotional pull there. And I was really fascinated with that because I sort of come from a very cerebral training of like, well, we've got this data and here are the patients for which benefit the most, and so therefore this is the natural conclusion of the decision you would make. In fact, it's far more complex than that and it's that complexity of human behavior that I got really interested in as I grew in the marketing organization. So I try to bring both the left and right brain such as it were to that thinking.Kat Vesce (03:53):As the best marketers do. We ask everyone this question, I want to go a little bit deeper. Is there a specific moment that changed the game for you as a marketer? Tell us your most defining career moment or pivot to date and what the obstacles were there.Erica Taylor (04:10):Yeah, I could probably name a few. I get the most depth in moments and insights when I actually get to interact with patients and with providers and sort of understand deeply their experiences. And one of the ahas that I got actually both in my sales and then later in my marketing role is that yes, Genentech, you guys have been trailblazing and biotech and you have been innovating, but the data is so complex even though I'm trained in this field with the patient loads that I see every day, I don't have time and you guys don't make it simple for us. And so the aha there is like, okay, then marketing campaigns have to really focus on taking very complex science, which I feel fortunate to understand, but boil it down to something that's very simple, that's very memorable. And the same for patients. Very often when I'm in conversations with providers, I have the patient in mind when I'm thinking about how I would want this medicine explained to me, and that is how I explain it to the provider thinking maybe if a couple of my phrasing or words sort of land, well then that's what gets repeated to the patient so that they understand the choices that they have before them.Kat Vesce (05:17):I love that. And as a biotech company now over 40 years old, how would you say your approach to campaign strategy differs from typical healthcare campaigns?Erica Taylor (05:25):Yeah, well for one,Kat Vesce (05:26):A little bit of that patient in mind.Erica Taylor (05:28):Yeah, the patient for sure in mind. And one of the things that I'm very happy to spearhead as the chief marketing officer is really thinking about how do we make that more and more personal? It's not the patient, it is the patient that may be a single parent that lives 45 minutes from their local healthcare system. How do I speak to that patient just as much as I speak to the patient that has a high powered career and really doesn't have the time to focus on themselves and needs something to be quick and convenient? And so really the opportunity before us is to figure out how to become more nuanced, relevant and personalized when we tell the stories of our medicines. What I love about Genentech and our ability to do that is we've always been focused on two things, patience and science. And as long as we keep those two centered in everything that we do, I think we're able to kind of meet that mark.(06:14):Maybe the other thing I'll add, because the idea of speaking in personalized ways is not new. It's not rocket science, it's not even the more complex things that we do, but the technology and the capabilities that exist maybe outside of healthcare are now being applied in our space. And so very excited about what things like generative AI can do for us and really being able to personalize our stories around our medicines and our development. But at scale, we market over 40 medicines, and so it's great to do this in one or two places, but imagine doing that across the full breadth of our portfolio.Kat Vesce (06:47):And I imagine that 40 medications or medicines times however many profiles fit the many faces of patients.Erica Taylor (06:57):Exactly.Kat Vesce (06:58):Yeah, you really need some automation there.Erica Taylor (07:00):Absolutely. The scale of the problem is impossible, and unless I'm getting sort of a complete blank check to build all the resources that I need, we've got to find ways to be more efficient with that.Ilyse Liffreing (07:09):So that has really got me thinking because as much as the customer is number one and everything, but you also have to speak to the provider and they're the ones who are going to be really selling your medicine to the patient themselves. How do you solve, I guess, for your need to resonate with both the customer provider and then who would you consider highest priority in those campaigns?Erica Taylor (07:34):No, it's a really, really great question. One of the things that I love about the healthcare space is that your decision maker and your end user are almost never the same person. And that's not totally unique. It's uncommon. But you could imagine parents buying baby formula are also decision makers, but generally not. And users, unless you were like me and got desperate and ran out of half and half and put baby formula in, coffee works great. Extra nutrients. Exactly. Yeah, life hack. So it's not totally unique, but you have to kind of speak to two audiences. So because of the breadth of our portfolio, we really do think about this disease state by disease state. So there are some disease states where really the provider is the driving decision maker. Examples of this can be if you're having a stroke and you're in the hospital, you're probably not deciding between which medications are right for now, you're really driven by the provider's decision maker.(08:31):You can think about that in some of our later line cancer portfolios. When you're in your past, your first two lines of treatment, you're really going to be relying on your provider to understand what are the next, so in those cases, we tend to focus more on the provider and the prescribing decision maker. There are other parts of our portfolio where it's really very much patient driven. We have a medicine that treats food allergy, and that really then tends to involve in some cases, adolescents, their parents. And so we really need to elevate their voices when we're thinking about how we make sure they have the right information. So it really can span the gamut, and it's about taking a specific view of that particular disease state and how decision-making is made.Ilyse Liffreing (09:09):That's amazing. Now the biotech category is not known for being exactly sexy when it comes to creative marketing. It's bogged down with side effects and similar storylines usually. How are you guys moving the needle in terms of creating those powerful maybe storytelling campaigns?Erica Taylor (09:30):Yeah, I mean, we are a regulated industry and I'll state first. It's actually really important that we give that information. Any medicine that anyone is going to take, you have to weigh the benefits and the risks, and it is on us to communicate that fairly. And so I very much stand behind that. As a scientist, we really have to do that, but that can also make it really hard to know what's what we're trying to do this. So for me, I always try to root in the emotion and what I tell my teams all the time at the end of everything we do is someone who is sick and scared and how do we really tap into that? What do they need in that moment of diagnosis? What do they need in that moment when they're a week out from treatment and they're not really sure if what they're experiencing is normal?(10:14):Really kind of capturing those moments along the patient's journey. And similarly for the provider's journey, if I were to be oversimplified providers saying 15, 20 patients a day, how do we find ways to make their challenging lives as easy as possible, as simple as possible? And so we kind of think of that almost in two tracks. Some of the best creative that I see really speaks to that emotion. We did a campaign in our ophthalmology franchise last year called A Beautiful Site, which really chronicles a parent watching their child go through the education and then that parent one day becoming a patient. And it's really a motive. We actually don't talk a ton about the medicine itself, but more the experience of what it's like when you're struggling with your eyesight and it's gotten a lot of traction just by speaking to that lived experience.Kat Vesce (11:03):We're going to shift the conversation and zoom out a little bit.Erica Taylor (11:05):Okay.Kat Vesce (11:05):Though biotech is not new by any means, the category was catapulted into the spotlight in mainstream media during the height of COVID-19 something very intimately a thing or two. Yes. Yeah. Gilead at the time, you saw this firsthand with your previous role. And tell us a little bit about that experience. What do you think has changed for the industry as a whole since then?Erica Taylor (11:27):Oh wow. So many things. I had so many reactions kind of experiencing as we all did. The sort of the Covid Ovid 19 crisis, the first among them is that science really became front and center. And as a scientist, I get excited, finally, we're getting the credit we deserve, but so much about it was what I understand is science. Science is slow and painstaking. It's a step forward, it's a step to the right, it's a step back. It's two steps forward. That is how science happens. The lay public for the most part just sees it at the end. And so you get to tell this story, but that's not actually how it went down. Think about your vaccines for things like polio. We weren't following the day to day of that. We just had it. And we go, great. That's wonderful science. So when looking through the vaccine development for Covid, we're kind of watching day by day, is it six feet?(12:17):What kind of mask? How do I do this? And so we got, I think people lost trust in science and that really was heartbreaking because that's actually how it is. And for me it's the resilience of the people that continue to pursue when you get up and the thing you thought was going to work didn't work today, and you get up tomorrow and go do it. And we were able to break through in that way. That's the one thing on the science side, on the marketing side, we now know names of biotech companies. No one generally does know that I get true. My branded medication, I get this branded, that branded medication. Now the names of the companies that produced the vaccines, you would go in and say, I want the Moderna one or the Pfizer one. That has never really happened before in our industry.(13:03):And we've had to go from being a sort of what I'll call a house of brands, the branded medication, to really thinking about, well, what is the worth in branding the house, the Genentechs of the world? We're actively thinking about how we do that, especially as we come to our 50th anniversary as a company next year. So I know there's a lot of activity and thinking, how do we strategically do this that is authentic to who we are as an organization and elevates all of the work that we do, all of the scientists that pursue day in and day out, all of the patients that we've been able to help improve the lives of.Kat Vesce (13:39):So in a world that we've been talking about has changed so much since Covid. Absolutely. People also expect more from companies than ever before. How do you align your corporate positioning with Genentech, with your creative output?Erica Taylor (13:51):Yeah. I think to me this is about relevance and authenticity. I think there's so much content in your life in and out of healthcare to consume, and I think people are far more discerning of what feels authentic to them, what feels true, what feels pandered to right today is International Women's Day. There's lots of celebrations around Women's Day. Not everyone has been consistent about really centering women and thinking about what are the things that women could benefit from and could use, I think, and the women walking around here today, they know the difference. And so I think for us, the onus is being true to who we are, being authentic, really, and as relevant as we can. And I think about that just sort of from the broader Genentech, but also how do we think about this product by product? What is the authentic experiences and where do we show up really matters? One of the things that I tell my teams all the time, I'm like, we'd say the word patient. They are people, which sounds obvious, but you can easily lose sight of the fact that the fact that someone is a patient is probably in the bottom five of the top 100 things they like about their life. So you want to be there when needed and the hell out of their lives when not. Right. And so how do we thread that line appropriately,Ilyse Liffreing (15:13):Right? Yeah,Erica Taylor (15:14):It's hard. It's hard. It's hard.Ilyse Liffreing (15:16):You could argue it's harder than your average CPG brandErica Taylor (15:19):ForIlyse Liffreing (15:19):Instance.Erica Taylor (15:20):Absolutely.Ilyse Liffreing (15:21):Absolutely.Erica Taylor (15:22):So it keeps it interesting for sureIlyse Liffreing (15:23):Yeah. Now, I know we kind of talked about this a little bit, but I wanted to zoom out here a little bit because of this trend, it seems like it's a trend anyway, and I'm curious what you think, but during the Super Bowl, there were stronger examples of creative lead pharma and biotech ads competing against the typical ads you would see during the Super Bowl usually. What do you think about this? Is that where we're moving as an industry?Erica Taylor (15:51):I think it's interesting. I feel like I'm a student of commercials. I actually personally love football, so I consume every second of the Super Bowl bowls for the game and then the ads that show. I think it's interesting and I think it's a space worth exploring as an industry. And I think we've seen, there's a Pfizer ad that was released this year. I think they did one last year as well. I think we're still trying to figure out how to land the mark. And Super Bowl is an interesting venue to do that. Most people don't want to see a drug commercial. They're eating nachos, they're watching a game, they're maybe cheering on a team, they're waiting for the halftime show, whatever. But how do you land in a space that is supposed to be celebratory in light with something that's relevant and important? I think it's worth exploring personally. I'm sort of like, let's see where there might be a relevant kind of meeting of the moment. And it might be specific to just that year, right? Or just this particular thing that we have in our portfolio that's innovative that we want to make sure people know about.(16:54):I don't know that I'd paint a brush and do it everywhere for all things personally, a hundredKat Vesce (16:58):Percent. ButErica Taylor (16:59):I'm sure there's probably other marketers on this listening here that'll say, no, you should be pushing. And I'm curious, sort of very curious about where this could go and interested to see,Ilyse Liffreing (17:10):Since we're at South by Southwest and this is International Women's Day, I'd love to get your take on some of these female focused questions. Sure. So first of all, what inspired you to pursue a career in marketing and how has your journey been as a woman in the industry? I know with your strong STEM background especially, do you feel like there's still a much needed boost in how women pursue stem?Erica Taylor (17:34):Well, I am particularly passionate about STEM fields and as a self-proclaimed and bonafide nerd, I think the more in which ways in which we can celebrate that the better. I think it is interesting. We've seen increasing percentages of women pursuing STEM careers, which I applaud. It's not even the painted, I think more in medicine and healthcare related fields, I think there's still more gains to be had in fields like engineering and computer science. And one of the things that are very critical if we want to truly unlock things like artificial intelligence, I think there's more to do there. But I feel very much the, I feel like I'm coming behind women that have gone before and have really blazed trails, and I feel the same responsibility to make sure that whatever trail someone believes I've blazed or not is easier for whoever comes behind me. And I feel a deep obligation that I spend a good amount of my time mentoring and developing everyone, not just women, but folks that are interested in, as I call it, being in places you're not supposed to be. I think it just makes for a an interesting career path and journey. And I don't know what I'll do in the future. I still dunno what I want to do when I grow up. I'm having a great time now. And so I look to mentors that help see, oh, okay, that's how you did that.Kat Vesce (18:59):Can we better support women in leadership roles? You mentioned mentorship. What are some other ways you're leaning into that?Erica Taylor (19:06):Yeah, I think it can come up in both direct ways, like mentorship. I think those programs benefit everyone. And both I learned from them and I learn a lot about some of the challenges that people face in their careers now. I think there's subtle ways. One of, I think the most powerful things that we can do is as leaders show up honestly and authentically and not be afraid of showing moments of vulnerability. And I think it humanizes you. I had an experience last year where my husband got very, very ill and I needed to have a pretty major surgery. He's doing great now. But sort of living through that and thinking about how do I do the job? I've asked, I've been asked to do, but show up authentically with my team and let them know, Hey, I've got kind of a lot going on at home right now and I don't even know that I navigated that line well. But more recently actually got up on stage in front of my full organization and kind of shared the story. And I did it in the context of marketing and what it meant to have healthcare providers sort give me exactly what I need in the moment to help support him through this.Kat Vesce (20:22):What a full circle moment.Erica Taylor (20:24):It was somewhat of a spontaneous decision, but I think as certainly women leaders as leaders, your podcasters don't know this, but I'm a woman of color, so a lot of things that are not typical about where I show up in spaces. And the more that I can make it that I'm still human, I'm still me, and I go through life the same way you do, you never know what people are walking around with kind of position. I think that helps invite others to say, okay, maybe I didn't get a PhD. Maybe I don't have these things, but I am as human as she is and maybe I can make it there too. I think there's value in that, even though I was literally shaking in my boots to tell that story to one stage, that's a hard thing to do. And fighting to keep my composure and be as authentic as I could. Well,Kat Vesce (21:13):That's the most humanErica Taylor (21:14):Response ever. Yeah.Kat Vesce (21:15):So inspiring. What advice would you give to the next generation of marketing leaders, including we talked about not just young women, but everyone looking to grow into that leadership role?Erica Taylor (21:29):Yeah, I usually give, and there's a couple schools of thought on this, so this is sort of Erica's school of thought on this, right? I think that you have to strike this balance between having depth of knowledge but getting breadth of experience. And it's a really hard one to thread, especially if you're doing something you love. You just want to do more and more and more and more. And there may be great growth paths to be had in that. But a lot of the advice that I give to folks, it's like every time you think about pursuing another role, I am going to apply for this role. It's a promotion, it's a lateral, it think two moves ahead. Does it unlock more options for you? And be very aware, my more senior leaders, I'm like, you have to understand you're at a point in your seniority where making lateral moves gets harder.(22:12):And so you want to make them in your earlier points in your career when you can. Because one, there's just more of those roles. I'm a vice president, there's not a lot of us at Genentech. And so if I want to move laterally, I have fewer options. I have to be that much more thoughtful about it. But I feel like I come at this with the space of a more breadth of experience, but you still got to know the job. So you kind of have to navigate this sort of, as I call it, the difference between scuba and snorkel. If you can scuba dive and go deep, understand that that has ramifications for your career development. If you only snorkel, also ramifications for your career development. And then the other piece of advice I give folks is try not to plan more than a couple of years ahead because 10 years from now, you're going to do a job that doesn't exist today.(22:59):So I'm first CMO, so I couldn't have won this job. It didn't exist until three years ago, right? Plan for a couple of years at a time. And if you're weighing a couple of options that are otherwise equal to you go with the team you'd rather have more fun with, go with the team. You want to come hang out in Austin, Texas with, right? And you're never going to go wrong. Working on teams that you enjoy with each other. We have a really great and strong culture at Genentech, and I'm always like, if you see a leader you want to go work with, find a way to get on that person's team. So those are usually the kinds of advice I give to everyone. And then maybe the other, and this is more, I'm of a certain age wouldn'tKat Vesce (23:41):Know it. PodcastersErica Taylor (23:43):Of a certain age worry a lot less, and someone gave me this advice, what am I going to do? How am I going to get that job? Blah, blah, blah. You've got to work a long time. Most if you're lucky, and many people do, and so worry a lot less about what's going to happen in a decade, worry a lot less about that person that's your peer that just got that promotion and they're going to go farther than you. Career path is their own and everything happens kind of exactly as it should. And so I try really hard to, especially for folks that I get the sort of fresh from business school and they're like, I've got to be CEO in five years. And I'm like, I don't dunno. Let's worry a little less about the timing and worry much more about the kinds of experiences you get to have along the way, what you get to learn and who you get to meet.Kat Vesce (24:37):Well,Erica Taylor (24:37):Erica, thank youKat Vesce (24:38):So much and thanks for your vulnerability and sharing those tidbits and stories. I so appreciate this time. I know we're both leaving really inspired soErica Taylor (24:46):Much. Thank you. I'm so happy to do this. I appreciate the invite. I hope it's helpful for your listeners. Yeah, no, it great. I'm sure it will be. Thank you so much. Thanks.Kat Vesce (24:55):Wow. I am blown away. I am walking away from that conversation with Erica Taylor. So inspired. I don't know about you.Ilyse Liffreing (25:02):Oh my gosh, yes. I love how vulnerable she was about talking about her husband, and not only to, I mean us, but to her whole company. And it takes a very brave and smart woman to be able to be open like that.Kat Vesce (25:17):And also what a full circle moment. I mean to be the CMO of a company that is marketing, I think she said 40 different medications, and then to be on the receiving end of that and navigating as your own family is going through the fear and intensity of recovering from an ailment.Ilyse Liffreing (25:40):As she said, everybody has their own stuff they're going through.Kat Vesce (25:43):Yeah. Yeah. That was really inspiring. I also just loved how she went into the tension that she faces as a marketer, which I can't think of any other category that has this same predicament of wanting to stay relevant and be top of mind for the inpatient or the provider, but also not wanting to be there all the time, and to be able to dip in and out when needed. Because ultimately her end goal she was saying was to keep people healthy. And so I think that's a really refreshing take, especially hearing it from a biotech company like Genentech, that you could hear horror stories about companies being incentivized to keep people sick. And I just loved that as a marketer. She's thinking through it from a place of just being authentic to getting people healthyIlyse Liffreing (26:35):Completely. And she also mentioned in a world like Post Covid, everybody now has their eyes on those companies, which is huge because pre covid, nobody knew what shots you were getting from whom. And now it's like, what shot did you get? The Pfizer or the Moderna.Kat Vesce (26:55):Yeah. And there was even some kind of ranking around them at one point. Yeah, totally. So yeah. Yeah, that's really interesting how biotech and pharma are now getting into the brand marketing side of the house. And I liked her answer that she's trepidatious about how and when to deploy that. So overall, just super inspiring conversation. I'm walking away just beaming talking to all these amazing women. That's wonderful. And that's it for this edition of the current podcast. Be sure to tune in this whole month as we release all the recordings from South by Southwest. See you next time.

Leite devia ser proibido? A verdade sobre os lácteos de acordo com Ayurveda e ciência moderna

As peace talks drag on, the crisis in Gaza gets worse and worse. It's now two weeks since Israel shut off electricity, food, fuel and medical supplies, in a bid to pressure Hamas to accept an extension of the preliminary ceasefire. Gavin Kelleher is the humanitarian access manager in Gaza for the Norwegian Refugee Council. He joins the show from Gaza City.  Also on today's show: Elizabeth Goitein, Senior Director, Liberty and National Security Program, Brennan Center for Justice; Noubar Afeyan, Co-Founder & Chairman, Moderna; Mary McCord, Former Acting Assistant Attorney General for National Security, DOJ  Learn more about your ad choices. Visit podcastchoices.com/adchoices

13 mars. Vilken verklighet döljer sig bakom SVT:s dramaserie om Jan Stenbecks liv? Andreas Ericson pratar med Susanna Popova som var chefredaktör för Stenbecks tidning Moderna tider, och Janerik Larsson som jobbade tillsammans med honom som vice vd på Kinnevik.

Capítulo completo #VC #emprender #parte2

Most investors focus on short-term or long-term rentals, but Jesse Vasquez found a sweet spot in between—and it changed everything.After skipping college and working in healthcare for years, Jesse struck gold by selling some his Moderna stock that he bought before the global COVID-19 pandemic and used it to launch a wildly successful real estate business focused on midterm rentals.In this episode, he breaks down how midterm rentals provide higher cash flow than traditional rentals with less turnover than Airbnbs—making them the perfect strategy for investors looking for stability and scalability. We dive into how he built a portfolio catering to high-paying tenants like traveling nurses and corporate professionals, the mindset shift required to walk away from a steady paycheck, and why networking and sales skills matter more than formal education.If you're looking for a recession-proof way to invest in real estate while maximizing returns, this episode is a must-listen. RESOURCES

Dr. Gary Null provides a commentary on "Universal  Healthcare"       Universal Healthcare is the Solution to a Broken Medical System Gary Null, PhD Progressive Radio Network, March 3, 2025 For over 50 years, there has been no concerted or successful effort to bring down medical costs in the American healthcare system. Nor are the federal health agencies making disease prevention a priority. Regardless whether the political left or right sponsors proposals for reform, such measures are repeatedly defeated by both parties in Congress. As a result, the nation's healthcare system remains one of the most expensive and least efficient in the developed world. For the past 30 years, medical bills contributing to personal debt regularly rank among the top three causes of personal bankruptcy. This is a reality that reflects not only the financial strain on ordinary Americans but the systemic failure of the healthcare system itself. The urgent question is: If President Trump and his administration are truly seeking to reduce the nation's $36 trillion deficit, why is there no serious effort to reform the most bloated and corrupt sector of the economy? A key obstacle is the widespread misinformation campaign that falsely claims universal health care would cost an additional $2 trillion annually and further balloon the national debt. However, a more honest assessment reveals the opposite. If the US adopted a universal single-payer system, the nation could actually save up to $20 trillion over the next 10 years rather than add to the deficit. Even with the most ambitious efforts by people like Elon Musk to rein in federal spending or optimize government efficiency, the estimated savings would only amount to $500 billion. This is only a fraction of what could be achieved through comprehensive healthcare reform alone. Healthcare is the largest single expenditure of the federal budget. A careful examination of where the $5 trillion spent annually on healthcare actually goes reveals massive systemic fraud and inefficiency. Aside from emergency medicine, which accounts for only 10-12 percent of total healthcare expenditures, the bulk of this spending does not deliver better health outcomes nor reduce trends in physical and mental illness. Applying Ockham's Razor, the principle that the simplest solution is often the best, the obvious conclusion is that America's astronomical healthcare costs are the direct result of price gouging on an unimaginable scale. For example, in most small businesses, profit margins range between 1.6 and 2.5 percent, such as in grocery retail. Yet the pharmaceutical industrial complex routinely operates on markup rates as high as 150,000 percent for many prescription drugs. The chart below highlights the astronomical gap between the retail price of some top-selling patented pharmaceutical medications and their generic equivalents. Drug Condition Patent Price (per unit) Generic Price Estimated Manufacture Cost Markup Source Insulin (Humalog) Diabetes $300 $30 $3 10,000% Rand (2021) EpiPen Allergic reactions $600 $30 $10 6,000% BMJ (2022) Daraprim Toxoplasmosis $750/pill $2 $0.50 150,000% JAMA (2019) Harvoni Hepatitis C $94,500 (12 weeks) $30,000 $200 47,000% WHO Report (2018) Lipitor Cholesterol $150 $10 $0.50 29,900% Health Affairs (2020) Xarelto Blood Thinner $450 $25 $1.50 30,000% NEJM (2020) Abilify Schizophrenia $800 (30 tablets) $15 $2 39,900% AJMC (2019) Revlimid Cancer $16,000/mo $450 $150 10,500% Kaiser Health News (2021) Humira Arthritis $2,984/dose $400 $50 5,868% Rand (2021) Sovaldi Hepatitis C $1,000/pill $10 $2 49,900% JAMA (2021) Xolair Asthma $2,400/dose $300 $50 4,800% NEJM (2020) Gleevec Leukemia $10,000/mo $350 $200 4,900% Harvard Public Health Review (2020) OxyContin Pain Relief $600 (30 tablets) $15 $0.50 119,900% BMJ (2022) Remdesivir Covid-19 $3,120 (5 doses) N/A $10 31,100% The Lancet (2020) The corruption extends far beyond price gouging. Many pharmaceutical companies convince federal health agencies to fund their basic research and drug development with taxpayer dollars. Yet when these companies bring successful products to market, the profits are kept entirely by the corporations or shared with the agencies or groups of government scientists. On the other hand, the public, who funded the research, receives no financial return. This amounts to a systemic betrayal of the public trust on a scale of hundreds of billions of dollars annually. Another significant contributor to rising healthcare costs is the widespread practice of defensive medicine that is driven by the constant threat of litigation. Over the past 40 years, defensive medicine has become a cottage industry. Physicians order excessive diagnostic tests and unnecessary treatments simply to protect themselves from lawsuits. Study after study has shown that these over-performed procedures not only inflate costs but lead to iatrogenesis or medical injury and death caused by the medical  system and practices itself. The solution is simple: adopting no-fault healthcare coverage for everyone where patients receive care without needing to sue and thereby freeing doctors from the burden of excessive malpractice insurance. A single-payer universal healthcare system could fundamentally transform the entire industry by capping profits at every level — from drug manufacturers to hospitals to medical equipment suppliers. The Department of Health and Human Services would have the authority to set profit margins for medical procedures. This would ensure that healthcare is determined by outcomes, not profits. Additionally, the growing influence of private equity firms and vulture capitalists buying up hospitals and medical clinics across America must be reined in. These equity firms prioritize profit extraction over improving the quality of care. They often slash staff, raise prices, and dictate medical procedures based on what will yield the highest returns. Another vital reform would be to provide free medical education for doctors and nurses in exchange for five years of service under the universal system. Medical professionals would earn a realistic salary cap to prevent them from being lured into equity partnerships or charging exorbitant rates. The biggest single expense in the current system, however, is the private health insurance industry, which consumes 33 percent of the $5 trillion healthcare budget. Health insurance CEOs consistently rank among the highest-paid executives in the country. Their companies, who are nothing more than bean counters, decide what procedures and drugs will be covered, partially covered, or denied altogether. This entire industry is designed to place profits above patients' lives. If the US dismantled its existing insurance-based system and replaced it with a fully reformed national healthcare model, the country could save $2.7 trillion annually while simultaneously improving health outcomes. Over the course of 10 years, those savings would amount to $27 trillion. This could wipe out nearly the entire national debt in a short time. This solution has been available for decades but has been systematically blocked by corporate lobbying and bipartisan corruption in Washington. The path forward is clear but only if American citizens demand a system where healthcare is valued as a public service and not a commodity. The national healthcare crisis is not just a fiscal issue. It is a crucial moral failure of the highest order. With the right reforms, the nation could simultaneously restore its financial health and deliver the kind of healthcare system its citizens have long deserved. American Healthcare: Corrupt, Broken and Lethal Richard Gale and Gary Null Progressive Radio Network, March 3, 2025 For a nation that prides itself on being the world's wealthiest, most innovative and technologically advanced, the US' healthcare system is nothing less than a disaster and disgrace. Not only are Americans the least healthy among the most developed nations, but the US' health system ranks dead last among high-income countries. Despite rising costs and our unshakeable faith in American medical exceptionalism, average life expectancy in the US has remained lower than other OECD nations for many years and continues to decline. The United Nations recognizes healthcare as a human right. In 2018, former UN Secretary General Ban Ki-moon denounced the American healthcare system as "politically and morally wrong." During the pandemic it is estimated that two to three years was lost on average life expectancy. On the other hand, before the Covid-19 pandemic, countries with universal healthcare coverage found their average life expectancy stable or slowly increasing. The fundamental problem in the U.S. is that politics have been far too beholden to the pharmaceutical, HMO and private insurance industries. Neither party has made any concerted effort to reign in the corruption of corporate campaign funding and do what is sensible, financially feasible and morally correct to improve Americans' quality of health and well-being.   The fact that our healthcare system is horribly broken is proof that moneyed interests have become so powerful to keep single-payer debate out of the media spotlight and censored. Poll after poll shows that the American public favors the expansion of public health coverage. Other incremental proposals, including Medicare and Medicaid buy-in plans, are also widely preferred to the Affordable Care Act or Obamacare mess we are currently stuck with.   It is not difficult to understand how the dismal state of American medicine is the result of a system that has been sold out to the free-market and the bottom line interests of drug makers and an inflated private insurance industry. How advanced and ethically sound can a healthcare system be if tens of millions of people have no access to medical care because it is financially out of their reach?  The figures speak for themselves. The U.S. is burdened with a $41 trillion Medicare liability. The number of uninsured has declined during the past several years but still lingers around 25 million. An additional 30-35 million are underinsured. There are currently 65 million Medicare enrollees and 89 million Medicaid recipients. This is an extremely unhealthy snapshot of the country's ability to provide affordable healthcare and it is certainly unsustainable. The system is a public economic failure, benefiting no one except the large and increasingly consolidated insurance and pharmaceutical firms at the top that supervise the racket.   Our political parties have wrestled with single-payer or universal healthcare for decades. Obama ran his first 2008 presidential campaign on a single-payer platform. Since 1985, his campaign health adviser, the late Dr. Quentin Young from the University of Illinois Medical School, was one of the nation's leading voices calling for universal health coverage.  During a private conversation with Dr. Young shortly before his passing in 2016, he conveyed his sense of betrayal at the hands of the Obama administration. Dr. Young was in his 80s when he joined the Obama campaign team to help lead the young Senator to victory on a promise that America would finally catch up with other nations. The doctor sounded defeated. He shared how he was manipulated, and that Obama held no sincere intention to make universal healthcare a part of his administration's agenda. During the closed-door negotiations, which spawned the weak and compromised Affordable Care Act, Dr. Young was neither consulted nor invited to participate. In fact, he told us that he never heard from Obama again after his White House victory.   Past efforts to even raise the issue have been viciously attacked. A huge army of private interests is determined to keep the public enslaved to private insurers and high medical costs. The failure of our healthcare is in no small measure due to it being a fully for-profit operation. Last year, private health insurance accounted for 65 percent of coverage. Consider that there are over 900 private insurance companies in the US. National Health Expenditures (NHE) grew to $4.5 trillion in 2022, which was 17.3 percent of GDP. Older corporate rank-and-file Democrats and Republicans argue that a single-payer or socialized medical program is unaffordable. However, not only is single-payer affordable, it will end bankruptcies due to unpayable medical debt. In addition, universal healthcare, structured on a preventative model, will reduce disease rates at the outset.    Corporate Democrats argue that Obama's Affordable Care Act (ACA) was a positive step inching the country towards complete public coverage. However, aside from providing coverage to the poorest of Americans, Obamacare turned into another financial anchor around the necks of millions more. According to the health policy research group KFF, the average annual health insurance premium for single coverage is $8,400 and almost $24,000 for a family. In addition, patient out-of-pocket costs continue to increase, a 6.6% increase to $471 billion in 2022. Rather than healthcare spending falling, it has exploded, and the Trump and Biden administrations made matters worse.    Clearly, a universal healthcare program will require flipping the script on the entire private insurance industry, which employed over half a million people last year.  Obviously, the most volatile debate concerning a national universal healthcare system concerns cost. Although there is already a socialized healthcare system in place -- every federal legislator, bureaucrat, government employee and veteran benefits from it -- fiscal Republican conservatives and groups such as the Koch Brothers network are single-mindedly dedicated to preventing the expansion of Medicare and Medicaid. A Koch-funded Mercatus analysis made the outrageous claim that a single-payer system would increase federal health spending by $32 trillion in ten years. However, analyses and reviews by the Congressional Budget Office in the early 1990s concluded that such a system would only increase spending at the start; enormous savings would quickly offset it as the years pass. In one analysis, "the savings in administrative costs [10 percent of health spending] would be more than enough to offset the expense of universal coverage."    Defenders of those advocating for funding a National Health Program argue this can primarily be accomplished by raising taxes to levels comparable to other developed nations. This was a platform Senator Bernie Sanders and some of the younger progressive Democrats in the House campaigned on. The strategy was to tax the highest multimillion-dollar earners 60-70 percent. Despite the outrage of its critics, including old rank-and-file multi-millionaire Democrats like Nancy Pelosi and Chuck Schumer, this is still far less than in the past. During the Korean War, the top tax rate was 91 percent; it declined to 70 percent in the late 1960s. Throughout most of the 1970s, those in the lowest income bracket were taxed at 14 percent. We are not advocating for this strategy because it ignores where the funding is going, and the corruption in the system that is contributing to exorbitant waste.    But Democratic supporters of the ACA who oppose a universal healthcare plan ignore the additional taxes Obama levied to pay for the program. These included surtaxes on investment income, Medicare taxes from those earning over $200,000, taxes on tanning services, an excise tax on medical equipment, and a 40 percent tax on health coverage for costs over the designated cap that applied to flexible savings and health savings accounts. The entire ACA was reckless, sloppy and unnecessarily complicated from the start.    The fact that Obamacare further strengthened the distinctions between two parallel systems -- federal and private -- with entirely different economic structures created a labyrinth of red tape, rules, and wasteful bureaucracy. Since the ACA went into effect, over 150 new boards, agencies and programs have had to be established to monitor its 2,700 pages of gibberish. A federal single-payer system would easily eliminate this bureaucracy and waste.    A medical New Deal to establish universal healthcare coverage is a decisive step in the correct direction. But we must look at the crisis holistically and in a systematic way. Simply shuffling private insurance into a federal Medicare-for-all or buy-in program, funded by taxing the wealthiest of citizens, would only temporarily reduce costs. It will neither curtail nor slash escalating disease rates e. Any effective healthcare reform must also tackle the underlying reasons for Americans' poor state of health. We cannot shy away from examining the social illnesses infecting our entire free-market capitalist culture and its addiction to deregulation. A viable healthcare model would have to structurally transform how the medical economy operates. Finally, a successful medical New Deal must honestly evaluate the best and most reliable scientific evidence in order to effectively redirect public health spending.    For example, Dr. Ezekiel Emanuel, a former Obama healthcare adviser, observed that AIDS-HIV measures consume the most public health spending, even though the disease "ranked 75th on the list of diseases by personal health expenditures." On the other hand, according to the American Medical Association, a large percentage of the nation's $3.4 trillion healthcare spending goes towards treating preventable diseases, notably diabetes, common forms of heart disease, and back and neck pain conditions. In 2016, these three conditions were the most costly and accounted for approximately $277 billion in spending. Last year, the CDC announced the autism rate is now 1 in 36 children compared to 1 in 44 two years ago. A retracted study by Mark Blaxill, an autism activist at the Holland Center and a friend of the authors, estimates that ASD costs will reach $589 billion annually by 2030. There are no signs that this alarming trend will reverse and decline; and yet, our entire federal health system has failed to conscientiously investigate the underlying causes of this epidemic. All explanations that might interfere with the pharmaceutical industry's unchecked growth, such as over-vaccination, are ignored and viciously discredited without any sound scientific evidence. Therefore, a proper medical New Deal will require a systemic overhaul and reform of our federal health agencies, especially the HHS, CDC and FDA. Only the Robert Kennedy Jr presidential campaign is even addressing the crisis and has an inexpensive and comprehensive plan to deal with it. For any medical revolution to succeed in advancing universal healthcare, the plan must prioritize spending in a manner that serves public health and not private interests. It will also require reshuffling private corporate interests and their lobbyists to the sidelines, away from any strategic planning, in order to break up the private interests' control over federal agencies and its revolving door policies. Aside from those who benefit from this medical corruption, the overwhelming majority of Americans would agree with this criticism. However, there is a complete lack of national trust that our legislators, including the so-called progressives, would be willing to undertake such actions.    In addition, America's healthcare system ignores the single most critical initiative to reduce costs - that is, preventative efforts and programs instead of deregulation and closing loopholes designed to protect the drug and insurance industries' bottom line. Prevention can begin with banning toxic chemicals that are proven health hazards associated with current disease epidemics, and it can begin by removing a 1,000-plus toxins already banned in Europe. This should be a no-brainer for any legislator who cares for public health. For example, Stacy Malkan, co-founder of the Campaign for Safe Cosmetics, notes that "the policy approach in the US and Europe is dramatically different" when it comes to chemical allowances in cosmetic products. Whereas the EU has banned 1,328 toxic substances from the cosmetic industry alone, the US has banned only 11. The US continues to allow carcinogenic formaldehyde, petroleum, forever chemicals, many parabens (an estrogen mimicker and endocrine hormone destroyer), the highly allergenic p-phenylenediamine or PBD, triclosan, which has been associated with the rise in antibiotic resistant bacteria, avobenzone, and many others to be used in cosmetics, sunscreens, shampoo and hair dyes.   Next, the food Americans consume can be reevaluated for its health benefits. There should be no hesitation to tax the unhealthiest foods, such as commercial junk food, sodas and candy relying on high fructose corn syrup, products that contain ingredients proven to be toxic, and meat products laden with dangerous chemicals including growth hormones and antibiotics. The scientific evidence that the average American diet is contributing to rising disease trends is indisputable. We could also implement additional taxes on the public advertising of these demonstrably unhealthy products. All such tax revenue would accrue to a national universal health program to offset medical expenditures associated with the very illnesses linked to these products. Although such tax measures would help pay for a new medical New Deal, it may be combined with programs to educate the public about healthy nutrition if it is to produce a reduction in the most common preventable diseases. In fact, comprehensive nutrition courses in medical schools should be mandatory because the average physician receives no education in this crucial subject.  In addition, preventative health education should be mandatory throughout public school systems.   Private insurers force hospitals, clinics and private physicians into financial corners, and this is contributing to prodigious waste in money and resources. Annually, healthcare spending towards medical liability insurance costs tens of billions of dollars. In particular, this economic burden has taxed small clinics and physicians. It is well past the time that physician liability insurance is replaced with no-fault options. Today's doctors are spending an inordinate amount of money to protect themselves. Legions of liability and trial lawyers seek big paydays for themselves stemming from physician error. This has created a culture of fear among doctors and hospitals, resulting in the overly cautious practice of defensive medicine, driving up costs and insurance premiums just to avoid lawsuits. Doctors are forced to order unnecessary tests and prescribe more medications and medical procedures just to cover their backsides. No-fault insurance is a common-sense plan that enables physicians to pursue their profession in a manner that will reduce iatrogenic injuries and costs. Individual cases requiring additional medical intervention and loss of income would still be compensated. This would generate huge savings.    No other nation suffers from the scourge of excessive drug price gouging like the US. After many years of haggling to lower prices and increase access to generic drugs, only a minute amount of progress has been made in recent years. A 60 Minutes feature about the Affordable Care Act reported an "orgy of lobbying and backroom deals in which just about everyone with a stake in the $3-trillion-a-year health industry came out ahead—except the taxpayers.” For example, Life Extension magazine reported that an antiviral cream (acyclovir), which had lost its patent protection, "was being sold to pharmacies for 7,500% over the active ingredient cost. The active ingredient (acyclovir) costs only 8 pennies, yet pharmacies are paying a generic maker $600 for this drug and selling it to consumers for around $700." Other examples include the antibiotic Doxycycline. The price per pill averages 7 cents to $3.36 but has a 5,300 percent markup when it reaches the consumer. The antidepressant Clomipramine is marked up 3,780 percent, and the anti-hypertensive drug Captopril's mark-up is 2,850 percent. And these are generic drugs!    Medication costs need to be dramatically cut to allow drug manufacturers a reasonable but not obscene profit margin. By capping profits approximately 100 percent above all costs, we would save our system hundreds of billions of dollars. Such a measure would also extirpate the growing corporate misdemeanors of pricing fraud, which forces patients to pay out-of-pocket in order to make up for the costs insurers are unwilling to pay.    Finally, we can acknowledge that our healthcare is fundamentally a despotic rationing system based upon high insurance costs vis-a-vis a toss of the dice to determine where a person sits on the economic ladder. For the past three decades it has contributed to inequality. The present insurance-based economic metrics cast millions of Americans out of coverage because private insurance costs are beyond their means. Uwe Reinhardt, a Princeton University political economist, has called our system "brutal" because it "rations [people] out of the system." He defined rationing as "withholding something from someone that is beneficial." Discriminatory healthcare rationing now affects upwards to 60 million people who have been either priced out of the system or under insured. They make too much to qualify for Medicare under Obamacare, yet earn far too little to afford private insurance costs and premiums. In the final analysis, the entire system is discriminatory and predatory.    However, we must be realistic. Almost every member of Congress has benefited from Big Pharma and private insurance lobbyists. The only way to begin to bring our healthcare program up to the level of a truly developed nation is to remove the drug industry's rampant and unnecessary profiteering from the equation.     How did Fauci memory-hole a cure for AIDS and get away with it?   By Helen Buyniski   Over 700,000 Americans have died of AIDS since 1981, with the disease claiming some 42.3 million victims worldwide. While an HIV diagnosis is no longer considered a certain death sentence, the disease looms large in the public imagination and in public health funding, with contemporary treatments running into thousands of dollars per patient annually.   But was there a cure for AIDS all this time - an affordable and safe treatment that was ruthlessly suppressed and attacked by the US public health bureaucracy and its agents? Could this have saved millions of lives and billions of dollars spent on AZT, ddI and failed HIV vaccine trials? What could possibly justify the decision to disappear a safe and effective approach down the memory hole?   The inventor of the cure, Gary Null, already had several decades of experience creating healing protocols for physicians to help patients not responding well to conventional treatments by the time AIDS was officially defined in 1981. Null, a registered dietitian and board-certified nutritionist with a PhD in human nutrition and public health science, was a senior research fellow and Director of Anti-Aging Medicine at the Institute of Applied Biology for 36 years and has published over 950 papers, conducting groundbreaking experiments in reversing biological aging as confirmed with DNA methylation testing. Additionally, Null is a multi-award-winning documentary filmmaker, bestselling author, and investigative journalist whose work exposing crimes against humanity over the last 50 years has highlighted abuses by Big Pharma, the military-industrial complex, the financial industry, and the permanent government stay-behind networks that have come to be known as the Deep State.   Null was contacted in 1974 by Dr. Stephen Caiazza, a physician working with a subculture of gay men in New York living the so-called “fast track” lifestyle, an extreme manifestation of the gay liberation movement that began with the Stonewall riots. Defined by rampant sexual promiscuity and copious use of illegal and prescription drugs, including heavy antibiotic use for a cornucopia of sexually-transmitted diseases, the fast-track never included more than about two percent of gay men, though these dominated many of the bathhouses and clubs that defined gay nightlife in the era. These patients had become seriously ill as a result of their indulgence, generally arriving at the clinic with multiple STDs including cytomegalovirus and several types of herpes and hepatitis, along with candida overgrowth, nutritional deficiencies, gut issues, and recurring pneumonia. Every week for the next 10 years, Null would counsel two or three of these men - a total of 800 patients - on how to detoxify their bodies and de-stress their lives, tracking their progress with Caiazza and the other providers at weekly feedback meetings that he credits with allowing the team to quickly evaluate which treatments were most effective. He observed that it only took about two years on the “fast track” for a healthy young person to begin seeing muscle loss and the recurrent, lingering opportunistic infections that would later come to be associated with AIDS - while those willing to commit to a healthier lifestyle could regain their health in about a year.    It was with this background that Null established the Tri-State Healing Center in Manhattan in 1980, staffing the facility with what would eventually run to 22 certified health professionals to offer safe, natural, and effective low- and no-cost treatments to thousands of patients with HIV and AIDS-defining conditions. Null and his staff used variations of the protocols he had perfected with Caiazza's patients, a multifactorial patient-tailored approach that included high-dose vitamin C drips, intravenous ozone therapy, juicing and nutritional improvements and supplementation, aspects of homeopathy and naturopathy with some Traditional Chinese Medicine and Ayurvedic practices. Additional services offered on-site included acupuncture and holistic dentistry, while peer support groups were also held at the facility so that patients could find community and a positive environment, healing their minds and spirits while they healed their bodies.   “Instead of trying to kill the virus with antiretroviral pharmaceuticals designed to stop viral replication before it kills patients, we focused on what benefits could be gained by building up the patients' natural immunity and restoring biochemical integrity so the body could fight for itself,” Null wrote in a 2014 article describing the philosophy behind the Center's approach, which was wholly at odds with the pharmaceutical model.1   Patients were comprehensively tested every week, with any “recovery” defined solely by the labs, which documented AIDS patient after patient - 1,200 of them - returning to good health and reversing their debilitating conditions. Null claims to have never lost an AIDS patient in the Center's care, even as the death toll for the disease - and its pharmaceutical standard of care AZT - reached an all-time high in the early 1990s. Eight patients who had opted for a more intensive course of treatment - visiting the Center six days a week rather than one - actually sero-deconverted, with repeated subsequent testing showing no trace of HIV in their bodies.   As an experienced clinical researcher himself, Null recognized that any claims made by the Center would be massively scrutinized, challenging as they did the prevailing scientific consensus that AIDS was an incurable, terminal illness. He freely gave his protocols to any medical practitioner who asked, understanding that his own work could be considered scientifically valid only if others could replicate it under the same conditions. After weeks of daily observational visits to the Center, Dr. Robert Cathcart took the protocols back to San Francisco, where he excitedly reported that patients were no longer dying in his care.    Null's own colleague at the Institute of Applied Biology, senior research fellow Elana Avram, set up IV drip rooms at the Institute and used his intensive protocols to sero-deconvert 10 patients over a two-year period. While the experiment had been conducted in secret, as the Institute had been funded by Big Pharma since its inception half a century earlier, Avram had hoped she would be able to publish a journal article to further publicize Null's protocols and potentially help AIDS patients, who were still dying at incredibly high rates thanks to Burroughs Wellcome's noxious but profitable AZT. But as she would later explain in a 2019 letter to Null, their groundbreaking research never made it into print - despite meticulous documentation of their successes - because the Institute's director and board feared their pharmaceutical benefactors would withdraw the funding on which they depended, given that Null's protocols did not involve any patentable or otherwise profitable drugs. When Avram approached them about publication, the board vetoed the idea, arguing that it would “draw negative attention because [the work] was contrary to standard drug treatments.” With no real point in continuing experiments along those lines without institutional support and no hope of obtaining funding from elsewhere, the department she had created specifically for these experiments shut down after a two-year followup with her test subjects - all of whom remained alive and healthy - was completed.2   While the Center was receiving regular visits by this time from medical professionals and, increasingly, black celebrities like Stokely Carmichael and Isaac Hayes, who would occasionally perform for the patients, the news was spreading by word of mouth alone - not a single media outlet had dared to document the clinic that was curing AIDS patients for free. Instead, they gave airtime to Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases, who had for years been spreading baseless, hysteria-fueling claims about HIV and AIDS to any news outlet that would put him on. His claim that children could contract the virus from “ordinary household conduct” with an infected relative proved so outrageous he had to walk it back,3 and he never really stopped insisting the deadly plague associated with gays and drug users was about to explode like a nuclear bomb among the law-abiding heterosexual population. Fauci by this time controlled all government science funding through NIAID, and his zero-tolerance approach to dissent on the HIV/AIDS front had already seen prominent scientists like virologist Peter Duesberg stripped of the resources they needed for their work because they had dared to question his commandment: There is no cause of AIDS but HIV, and AZT is its treatment. Even the AIDS activist groups, which by then had been coopted by Big Pharma and essentially reduced to astroturfing for the toxic failed chemotherapy drug AZT backed by the institutional might of Fauci's NIAID,4 didn't seem to want to hear that there was a cure. Unconcerned with the irrationality of denouncing the man touting his free AIDS cure as an  “AIDS denier,” they warned journalists that platforming Null or anyone else rejecting the mainstream medical line would be met with organized demands for their firing.    Determined to breach the institutional iron curtain and get his message to the masses, Null and his team staged a press conference in New York, inviting scientists and doctors from around the world to share their research on alternative approaches to HIV and AIDS in 1993. To emphasize the sound scientific basis of the Center's protocols and encourage guests to adopt them into their own practices, Null printed out thousands of abstracts in support of each nutrient and treatment being used. However, despite over 7,000 invitations sent three times to major media, government figures, scientists, and activists, almost none of the intended audience members showed up. Over 100 AIDS patients and their doctors, whose charts exhaustively documented their improvements using natural and nontoxic modalities over the preceding 12 months, gave filmed testimonials, declaring that the feared disease was no longer a death sentence, but the conference had effectively been silenced. Bill Tatum, publisher of the Amsterdam News, suggested Null and his patients would find a more welcoming audience in his home neighborhood of Harlem - specifically, its iconic Apollo Theatre. For three nights, the theater was packed to capacity. Hit especially hard by the epidemic and distrustful of a medical system that had only recently stopped being openly racist (the Tuskegee syphilis experiment only ended in 1972), black Americans, at least, did not seem to care what Anthony Fauci would do if he found out they were investigating alternatives to AZT and death.    PBS journalist Tony Brown, having obtained a copy of the video of patient testimonials from the failed press conference, was among a handful of black journalists who began visiting the Center to investigate the legitimacy of Null's claims. Satisfied they had something significant to offer his audience, Brown invited eight patients - along with Null himself - onto his program over the course of several episodes to discuss the work. It was the first time these protocols had received any attention in the media, despite Null having released nearly two dozen articles and multiple documentaries on the subject by that time. A typical patient on one program, Al, a recovered IV drug user who was diagnosed with AIDS at age 32, described how he “panicked,” saw a doctor and started taking AZT despite his misgivings - only to be forced to discontinue the drug after just a few weeks due to his condition deteriorating rapidly. Researching alternatives brought him to Null, and after six months of “detoxing [his] lifestyle,” he observed his initial symptoms - swollen lymph nodes and weight loss - begin to reverse, culminating with sero-deconversion. On Bill McCreary's Channel 5 program, a married couple diagnosed with HIV described how they watched their T-cell counts increase as they cut out sugar, caffeine, smoking, and drinking and began eating a healthy diet. They also saw the virus leave their bodies.   For HIV-positive viewers surrounded by fear and negativity, watching healthy-looking, cheerful “AIDS patients” detail their recovery while Null backed up their claims with charts must have been balm for the soul. But the TV programs were also a form of outreach to the medical community, with patients' charts always on hand to convince skeptics the cure was scientifically valid. Null brought patients' charts to every program, urging them to keep an open mind: “Other physicians and public health officials should know that there's good science in the alternative perspective. It may not be a therapy that they're familiar with, because they're just not trained in it, but if the results are positive, and you can document them…” He challenged doubters to send in charts from their own sero-deconverted patients on AZT, and volunteered to debate proponents of the orthodox treatment paradigm - though the NIH and WHO both refused to participate in such a debate on Tony Brown's Journal, following Fauci's directive prohibiting engagement with forbidden ideas.    Aside from those few TV programs and Null's own films, suppression of Null's AIDS cure beyond word of mouth was total. The 2021 documentary The Cost of Denial, produced by the Society for Independent Journalists, tells the story of the Tri-State Healing Center and the medical paradigm that sought to destroy it, lamenting the loss of the lives that might have been saved in a more enlightened society. Nurse practitioner Luanne Pennesi, who treated many of the AIDS patients at the Center, speculated in the film that the refusal by the scientific establishment and AIDS activists to accept their successes was financially motivated. “It was as if they didn't want this information to get out. Understand that our healthcare system as we know it is a corporation, it's a corporate model, and it's about generating revenue. My concern was that maybe they couldn't generate enough revenue from these natural approaches.”5   Funding was certainly the main disciplinary tool Fauci's NIAID used to keep the scientific community in line. Despite the massive community interest in the work being done at the Center, no foundation or institution would defy Fauci and risk getting itself blacklisted, leaving Null to continue funding the operation out of his pocket with the profits from book sales. After 15 years, he left the Center in 1995, convinced the mainstream model had so thoroughly been institutionalized that there was no chance of overthrowing it. He has continued to counsel patients and advocate for a reappraisal of the HIV=AIDS hypothesis and its pharmaceutical treatments, highlighting the deeply flawed science underpinning the model of the disease espoused by the scientific establishment in 39 articles, six documentaries and a 700-page textbook on AIDS, but the Center's achievements have been effectively memory-holed by Fauci's multi-billion-dollar propaganda apparatus.     FRUIT OF THE POISONOUS TREE   To understand just how much of a threat Null's work was to the HIV/AIDS establishment, it is instructive to revisit the 1984 paper, published by Dr. Robert Gallo of the National Cancer Institute, that established HIV as the sole cause of AIDS. The CDC's official recognition of AIDS in 1981 had done little to quell the mounting public panic over the mysterious illness afflicting gay men in the US, as the agency had effectively admitted it had no idea what was causing them to sicken and die. As years passed with no progress determining the causative agent of the plague, activist groups like Gay Men's Health Crisis disrupted public events and threatened further mass civil disobedience as they excoriated the NIH for its sluggish allocation of government science funding to uncovering the cause of the “gay cancer.”6 When Gallo published his paper declaring that the retrovirus we now know as HIV was the sole “probable” cause of AIDS, its simple, single-factor hypothesis was the answer to the scientific establishment's prayers. This was particularly true for Fauci, as the NIAID chief was able to claim the hot new disease as his agency's own domain in what has been described as a “dramatic confrontation” with his rival Sam Broder at the National Cancer Institute. After all, Fauci pointed out, Gallo's findings - presented by Health and Human Services Secretary Margaret Heckler as if they were gospel truth before any other scientists had had a chance to inspect them, never mind conduct a full peer review - clearly classified AIDS as an infectious disease, and not a cancer like the Kaposi's sarcoma which was at the time its most visible manifestation. Money and media attention began pouring in, even as funding for the investigation of other potential causes of AIDS dried up. Having already patented a diagnostic test for “his” retrovirus before introducing it to the world, Gallo was poised for a financial windfall, while Fauci was busily leveraging the discovery into full bureaucratic empire of the US scientific apparatus.   While it would serve as the sole basis for all US government-backed AIDS research to follow - quickly turning Gallo into the most-cited scientist in the world during the 1980s,7 Gallo's “discovery” of HIV was deeply problematic. The sample that yielded the momentous discovery actually belonged to Prof. Luc Montagnier of the French Institut Pasteur, a fact Gallo finally admitted in 1991, four years after a lawsuit from the French government challenged his patent on the HIV antibody test, forcing the US government to negotiate a hasty profit-sharing agreement between Gallo's and Montagnier's labs. That lawsuit triggered a cascade of official investigations into scientific misconduct by Gallo, and evidence submitted during one of these probes, unearthed in 2008 by journalist Janine Roberts, revealed a much deeper problem with the seminal “discovery.” While Gallo's co-author, Mikulas Popovic, had concluded after numerous experiments with the French samples that the virus they contained was not the cause of AIDS, Gallo had drastically altered the paper's conclusion, scribbling his notes in the margins, and submitted it for publication to the journal Science without informing his co-author.   After Roberts shared her discovery with contacts in the scientific community, 37 scientific experts wrote to the journal demanding that Gallo's career-defining HIV paper be retracted from Science for lacking scientific integrity.8 Their call, backed by an endorsement from the 2,600-member scientific organization Rethinking AIDS, was ignored by the publication and by the rest of mainstream science despite - or perhaps because of - its profound implications.   That 2008 letter, addressed to Science editor-in-chief Bruce Alberts and copied to American Association for the Advancement of Science CEO Alan Leshner, is worth reproducing here in its entirety, as it utterly dismantles Gallo's hypothesis - and with them the entire HIV is the sole cause of AIDS dogma upon which the contemporary medical model of the disease rests:   On May 4, 1984 your journal published four papers by a group led by Dr. Robert Gallo. We are writing to express our serious concerns with regard to the integrity and veracity of the lead paper among these four of which Dr. Mikulas Popovic is the lead author.[1] The other three are also of concern because they rely upon the conclusions of the lead paper .[2][3][4]  In the early 1990s, several highly critical reports on the research underlying these papers were produced as a result of governmental inquiries working under the supervision of scientists nominated by the National Academy of Sciences and the Institute of Medicine. The Office of Research Integrity of the US Department of Health and Human Services concluded that the lead paper was “fraught with false and erroneous statements,” and that the “ORI believes that the careless and unacceptable keeping of research records...reflects irresponsible laboratory management that has permanently impaired the ability to retrace the important steps taken.”[5] Further, a Congressional Subcommittee on Oversight and Investigations led by US Representative John D. Dingell of Michigan produced a staff report on the papers which contains scathing criticisms of their integrity.[6]  Despite the publically available record of challenges to their veracity, these papers have remained uncorrected and continue to be part of the scientific record.  What prompts our communication today is the recent revelation of an astonishing number of previously unreported deletions and unjustified alterations made by Gallo to the lead paper. There are several documents originating from Gallo's laboratory that, while available for some time, have only recently been fully analyzed. These include a draft of the lead paper typewritten by Popovic which contains handwritten changes made to it by Gallo.[7] This draft was the key evidence used in the above described inquiries to establish that Gallo had concealed his laboratory's use of a cell culture sample (known as LAV) which it received from the Institut Pasteur.  These earlier inquiries verified that the typed manuscript draft was produced by Popovic who had carried out the recorded experiment while his laboratory chief, Gallo, was in Europe and that, upon his return, Gallo changed the document by hand a few days before it was submitted to Science on March 30, 1984. According to the ORI investigation, “Dr. Gallo systematically rewrote the manuscript for what would become a renowned LTCB [Gallo's laboratory at the National Cancer Institute] paper.”[5]  This document provided the important evidence that established the basis for awarding Dr. Luc Montagnier and Dr. Francoise Barré-Sinoussi the 2008 Nobel Prize in Medicine for the discovery of the AIDS virus by proving it was their samples of LAV that Popovic used in his key experiment. The draft reveals that Popovic had forthrightly admitted using the French samples of LAV renamed as Gallo's virus, HTLV-III, and that Gallo had deleted this admission, concealing their use of LAV.  However, it has not been previously reported that on page three of this same document Gallo had also deleted Popovic's unambiguous statement that, "Despite intensive research efforts, the causative agent of AIDS has not yet been identified,” replacing it in the published paper with a statement that said practically the opposite, namely, “That a retrovirus of the HTLV family might be an etiologic agent of AIDS was suggested by the findings.”  It is clear that the rest of Popovic's typed paper is entirely consistent with his statement that the cause of AIDS had not been found, despite his use of the French LAV. Popovic's final conclusion was that the culture he produced “provides the possibility” for detailed studies. He claimed to have achieved nothing more. At no point in his paper did Popovic attempt to prove that any virus caused AIDS, and it is evident that Gallo concealed these key elements in Popovic's experimental findings.  It is astonishing now to discover these unreported changes to such a seminal document. We can only assume that Gallo's alterations of Popovic's conclusions were not highlighted by earlier inquiries because the focus at the time was on establishing that the sample used by Gallo's lab came from Montagnier and was not independently collected by Gallo. In fact, the only attention paid to the deletions made by Gallo pertains to his effort to hide the identity of the sample. The questions of whether Gallo and Popovic's research proved that LAV or any other virus was the cause of AIDS were clearly not considered.  Related to these questions are other long overlooked documents that merit your attention. One of these is a letter from Dr. Matthew A. Gonda, then Head of the Electron Microscopy Laboratory at the National Cancer Institute, which is addressed to Popovic, copied to Gallo and dated just four days prior to Gallo's submission to Science.[8] In this letter, Gonda remarks on samples he had been sent for imaging because “Dr Gallo wanted these micrographs for publication because they contain HTLV.” He states, “I do not believe any of the particles photographed are of HTLV-I, II or III.” According to Gonda, one sample contained cellular debris, while another had no particles near the size of a retrovirus. Despite Gonda's clearly worded statement, Science published on May 4, 1984 papers attributed to Gallo et al with micrographs attributed to Gonda and described unequivocally as HTLV-III.  In another letter by Gallo, dated one day before he submitted his papers to Science, Gallo states, “It's extremely rare to find fresh cells [from AIDS patients] expressing the virus... cell culture seems to be necessary to induce virus,” a statement which raises the possibility he was working with a laboratory artifact. [9]  Included here are copies of these documents and links to the same. The very serious flaws they reveal in the preparation of the lead paper published in your journal in 1984 prompts our request that this paper be withdrawn. It appears that key experimental findings have been concealed. We further request that the three associated papers published on the same date also be withdrawn as they depend on the accuracy of this paper.  For the scientific record to be reliable, it is vital that papers shown to be flawed, or falsified be retracted. Because a very public record now exists showing that the Gallo papers drew unjustified conclusions, their withdrawal from Science is all the more important to maintain integrity. Future researchers must also understand they cannot rely on the 1984 Gallo papers for statements about HIV and AIDS, and all authors of papers that previously relied on this set of four papers should have the opportunity to consider whether their own conclusions are weakened by these revelations.      Gallo's handwritten revision, submitted without his colleague's knowledge despite multiple experiments that failed to support the new conclusion, was the sole foundation for the HIV=AIDS hypothesis. Had Science published the manuscript the way Popovic had typed it, there would be no AIDS “pandemic” - merely small clusters of people with AIDS. Without a viral hypothesis backing the development of expensive and deadly pharmaceuticals, would Fauci have allowed these patients to learn about the cure that existed all along?   Faced with a potential rebellion, Fauci marshaled the full resources under his control to squelch the publication of the investigations into Gallo and restrict any discussion of competing hypotheses in the scientific and mainstream press, which had been running virus-scare stories full-time since 1984. The effect was total, according to biochemist Dr. Kary Mullis, inventor of the polymerase chain reaction (PCR) procedure. In a 2009 interview, Mullis recalled his own shock when he attempted to unearth the experimental basis for the HIV=AIDS hypothesis. Despite his extensive inquiry into the literature, “there wasn't a scientific reference…[that] said ‘here's how come we know that HIV is the probable cause of AIDS.' There was nothing out there like that.”9 This yawning void at the core of HIV/AIDS “science" turned him into a strident critic of AIDS dogma - and those views made him persona non grata where the scientific press was concerned, suddenly unable to publish a single paper despite having won the Nobel Prize for his invention of the PCR test just weeks before.  10   DISSENT BECOMES “DENIAL”   While many of those who dissent from the orthodox HIV=AIDS view believe HIV plays a role in the development of AIDS, they point to lifestyle and other co-factors as being equally if not more important. Individuals who test positive for HIV can live for decades in perfect health - so long as they don't take AZT or the other toxic antivirals fast-tracked by Fauci's NIAID - but those who developed full-blown AIDS generally engaged in highly risky behaviors like extreme promiscuity and prodigious drug abuse, contracting STDs they took large quantities of antibiotics to treat, further running down their immune systems. While AIDS was largely portrayed as a “gay disease,” it was only the “fast track” gays, hooking up with dozens of partners nightly in sex marathons fueled by “poppers” (nitrate inhalants notorious for their own devastating effects on the immune system), who became sick. Kaposi's sarcoma, one of the original AIDS-defining conditions, was widespread among poppers-using gay men, but never appeared among IV drug users or hemophiliacs, the other two main risk groups during the early years of the epidemic. Even Robert Gallo himself, at a 1994 conference on poppers held by the National Institute on Drug Abuse, would admit that the previously-rare form of skin cancer surging among gay men was not primarily caused by HIV - and that it was immune stimulation, rather than suppression, that was likely responsible.11 Similarly, IV drug users are often riddled with opportunistic infections as their habit depresses the immune system and their focus on maintaining their addiction means that healthier habits - like good nutrition and even basic hygiene - fall by the wayside.    Supporting the call for revising the HIV=AIDS hypothesis to include co-factors is the fact that the mass heterosexual outbreaks long predicted by Fauci and his ilk in seemingly every country on Earth have failed to materialize, except - supposedly - in Africa, where the diagnostic standard for AIDS differs dramatically from those of the West. Given the prohibitively high cost of HIV testing for poor African nations, the WHO in 1985 crafted a diagnostic loophole that became known as the “Bangui definition,” allowing medical professionals to diagnose AIDS in the absence of a test using just clinical symptoms: high fever, persistent cough, at least 30 days of diarrhea, and the loss of 10% of one's body weight within two months. Often suffering from malnutrition and without access to clean drinking water, many of the inhabitants of sub-Saharan Africa fit the bill, especially when the WHO added tuberculosis to the list of AIDS-defining illnesses in 1993 - a move which may be responsible for as many as one half of African “AIDS” cases, according to journalist Christine Johnson. The WHO's former Chief of Global HIV Surveillance, James Chin, acknowledged their manipulation of statistics, but stressed that it was the entire AIDS industry - not just his organization - perpetrating the fraud. “There's the saying that, if you knew what sausages are made of, most people would hesitate to sort of eat them, because they wouldn't like what's in it. And if you knew how HIV/AIDS numbers are cooked, or made up, you would use them with extreme caution,” Chin told an interviewer in 2009.12   With infected numbers stubbornly remaining constant in the US despite Fauci's fearmongering projections of the looming heterosexually-transmitted plague, the CDC in 1993 broadened its definition of AIDS to include asymptomatic (that is, healthy) HIV-positive people with low T-cell counts - an absurd criteria given that an individual's T-cell count can fluctuate by hundreds within a single day. As a result, the number of “AIDS cases” in the US immediately doubled. Supervised by Fauci, the NIAID had been quietly piling on diseases into the “AIDS-related” category for years, bloating the list from just two conditions - pneumocystis carinii pneumonia and Kaposi's sarcoma - to 30 so fast it raised eyebrows among some of science's leading lights. Deeming the entire process “bizarre” and unprecedented, Kary Mullis wondered aloud why no one had called the AIDS establishment out: “There's something wrong here. And it's got to be financial.”13   Indeed, an early CDC public relations campaign was exposed by the Wall Street Journal in 1987 as having deliberately mischaracterized AIDS as a threat to the entire population so as to garner increased public and private funding for what was very much a niche issue, with the risk to average heterosexuals from a single act of sex “smaller than the risk of ever getting hit by lightning.” Ironically, the ads, which sought to humanize AIDS patients in an era when few Americans knew anyone with the disease and more than half the adult population thought infected people should be forced to carry cards warning of their status, could be seen as a reaction to the fear tactics deployed by Fauci early on.14   It's hard to tell where fraud ends and incompetence begins with Gallo's HIV antibody test. Much like Covid-19 would become a “pandemic of testing,” with murder victims and motorcycle crashes lumped into “Covid deaths” thanks to over-sensitized PCR tests that yielded as many as 90% false positives,15 HIV testing is fraught with false positives - and unlike with Covid-19, most people who hear they are HIV-positive still believe they are receiving a death sentence. Due to the difficulty of isolating HIV itself from human samples, the most common diagnostic tests, ELISA and the Western Blot, are designed to detect not the virus but antibodies to it, upending the traditional medical understanding that the presence of antibodies indicates only exposure - and often that the body has actually vanquished the pathogen. Patients are known to test positive for HIV antibodies in the absence of the virus due to at least 70 other conditions, including hepatitis, lupus, rheumatoid arthritis, syphilis, recent vaccination or even pregnancy. (https://www.chcfl.org/diseases-that-can-cause-a-false-positive-hiv-test/) Positive results are often followed up with a PCR “viral load” test, even though the inventor of the PCR technique Kary Mullis famously condemned its misuse as a tool for diagnosing infection. Packaging inserts for all three tests warn the user that they cannot be reliably used to diagnose HIV.16 The ELISA HIV antibody test explicitly states: “At present there is no recognized standard for establishing the presence and absence of HIV antibody in human blood.”17   That the public remains largely unaware of these and other massive holes in the supposedly airtight HIV=AIDS=DEATH paradigm is a testament to Fauci's multi-layered control of the press. Like the writers of the Great Barrington Declaration and other Covid-19 dissidents, scientists who question HIV/AIDS dogma have been brutally punished for their heresy, no matter how prestigious their prior standing in the field and no matter how much evidence they have for their own claims. In 1987, the year the FDA's approval of AZT made AIDS the most profitable epidemic yet (a dubious designation Covid-19 has since surpassed), Fauci made it clearer than ever that scientific inquiry and debate - the basis of the scientific method - would no longer be welcome in the American public health sector, eliminating retrovirologist Peter Duesberg, then one of the most prominent opponents of the HIV=AIDS hypothesis, from the scientific conversation with a professional disemboweling that would make a cartel hitman blush. Duesberg had just eviscerated Gallo's 1984 HIV paper with an article of his own in the journal Cancer Research, pointing out that retroviruses had never before been found to cause a single disease in humans - let alone 30 AIDS-defining diseases. Rather than allow Gallo or any of the other scientists in his camp to respond to the challenge, Fauci waged a scorched-earth campaign against Duesberg, who had until then been one of the most highly regarded researchers in his field. Every research grant he requested was denied; every media appearance was canceled or preempted. The University of California at Berkeley, unable to fully fire him due to tenure, took away his lab, his graduate students, and the rest of his funding. The few colleagues who dared speak up for him in public were also attacked, while enemies and opportunists were encouraged to slander Duesberg at the conferences he was barred from attending and in the journals that would no longer publish his replies. When Duesberg was summoned to the White House later that year by then-President Ronald Reagan to debate Fauci on the origins of AIDS, Fauci convinced the president to cancel, allegedly pulling rank on the Commander-in-Chief with an accusation that the “White House was interfering in scientific matters that belonged to the NIH and the Office of Science and Technology Assessment.” After seven years of this treatment, Duesberg was contacted by NIH official Stephen O'Brien and offered an escape from professional purgatory. He could have “everything back,” he was told, and shown a manuscript of a scientific paper - apparently commissioned by the editor of the journal Nature - “HIV Causes AIDS: Koch's Postulates Fulfilled” with his own name listed alongside O'Brien's as an author.18 His refusal to take the bribe effectively guaranteed the epithet “AIDS denier” will appear on his tombstone. The character assassination of Duesberg became a template that would be deployed to great effectiveness wherever Fauci encountered dissent - never debate, only demonize, deplatform and destroy.    Even Luc Montagnier, the real discoverer of HIV, soon found himself on the wrong side of the Fauci machine. With his 1990 declaration that “the HIV virus [by itself] is harmless and passive, a benign virus,” Montagnier began distancing himself from Gallo's fraud, effectively placing a target on his own back. In a 1995 interview, he elaborated: “four factors that have come together to account for the sudden epidemic [of AIDS]: HIV presence, immune hyper-activation, increased sexually transmitted disease incidence, sexual behavior changes and other behavioral changes” such as drug use, poor nutrition and stress - all of which he said had to occur “essentially simultaneously” for HIV to be transmitted, creating the modern epidemic. Like the professionals at the Tri-State Healing Center, Montagnier advocated for the use of antioxidants like vitamin C and N-acetyl cysteine, naming oxidative stress as a critical factor in the progression from HIV to AIDS.19 When Montagnier died in 2022, Fauci's media mouthpieces sneered that the scientist (who was awarded the Nobel Prize in 2008 for his discovery of HIV, despite his flagging faith in that discovery's significance) “started espousing views devoid of a scientific basis” in the late 2000s, leading him to be “shunned by the scientific community.”20 In a particularly egregious jab, the Washington Post's obit sings the praises of Robert Gallo, implying it was the American scientist who really should have won the Nobel for HIV, while dismissing as “

We dig into that psychotic AI video of Trump Gaza, and the Goth Ninjas AI theme song. Elon Musk lied about resuming ebola prevention. Donald and RFK might pull funding for the Moderna bird flu vaccine. USAID is about to be eliminated. Large scale layoffs are next. Social Security on the chopping block. Veterans aren't safe either. Bob goes off about anti-woke comedians and the persecution of trans people. You Were Warned! and a new jingle from Chris Kolling. With Jody Hamilton, David Ferguson, music by Hunger Anthem, Heather Lynne Horton, and more!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Investors continue to digest the new administration's plans on tariffs and federal spending cuts. Plus: Nvidia shares continue to fall after the company reported forecast-beating results. And Federal Health officials are reportedly reviewing Moderna's almost $600 million contract to help develop a bird flu vaccine. Anthony Bansie hosts.  Sign up for the WSJ's free What's News newsletter.   Learn more about your ad choices. Visit megaphone.fm/adchoices